{
    "0": {
        "reasoning": "1. Looking at the Consolidated Statement of Cash Flows in the context\n2. Under \"Cash Flows from Investing Activities\" section, there's a line item \"Purchases and (PP&E)\" which represents capital expenditures\n3. For the year 2018, the amount shown is $(1,577) million\n4. The negative sign indicates this is a cash outflow, which is typical for capital expenditures\n5. This same figure is also confirmed in the \"Free Cash Flow\" reconciliation section where \"Purchases of property, plant and equipment (PP&E)\" shows $(1,577) million for 2018",
        "answer": "$1,577 million"
    },
    "1": {
        "reasoning": "1. Looking at the consolidated balance sheet (page 56), I can find the Property, Plant and Equipment (PP&E) information\n2. The balance sheet shows:\n   - Gross PP&E of $24,873 million\n   - Less: Accumulated depreciation of $(16,135) million\n3. Net PP&E is calculated by subtracting accumulated depreciation from gross PP&E\n4. The calculation is: $24,873M - $16,135M = $8,738M\n5. Converting to billions: $8.738 billion",
        "answer": "$8.738 billion"
    },
    "2": {
        "reasoning": "1. Analyzing the capital spending information from the context:\n- 3M expects 2023 capital spending to be approximately $1.5 billion to $1.8 billion\n- Company invests in multiple areas including:\n  * Renewal and maintenance programs\n  * Growth initiatives and capacity expansion\n  * Information technology\n  * Laboratory facilities\n  * Sustainability investments\n\n2. Examining the nature of investments:\n- Investments are made in property, plant and equipment across diverse markets\n- Focus on manufacturing efficiency and product demand\n- Significant investment in manufacturing and sourcing capability globally\n- Regular investments in pollution elimination and compliance\n- Continuous investment in new facilities and expansion of current facilities\n\n3. Evaluating the strategic importance:\n- Capital investments are considered crucial for:\n  * Meeting product demand\n  * Increasing manufacturing efficiency\n  * Aligning product capability with global sales\n  * Maintaining competitive advantage through proprietary, automated processes\n  * Ensuring sustainable operations\n\n4. Based on the level of capital expenditure ($1.5-1.8B forecast) and the broad scope of capital investments required for operations, manufacturing, and maintenance, 3M demonstrates characteristics of a capital-intensive business.",
        "answer": "Yes, 3M is a capital-intensive business, as evidenced by its substantial projected capital spending of $1.5-1.8 billion for 2023 and its continuous need for significant investments in manufacturing facilities, equipment, and infrastructure to maintain and grow its operations."
    },
    "3": {
        "reasoning": "1. From analyzing the context, several factors impacted 3M's operational performance in 2022:\n   - Significant litigation costs of approximately $2.3 billion pre-tax\n   - PFAS-related matters charges of $355 million\n   - Gain of $2.7 billion from Food Safety Division split-off\n   - $0.8 billion charge related to PFAS manufacturing exit\n   - Impact from COVID-19 on demand and supply chains\n   - Suspension of operations in Russia\n   - Raw materials and logistics cost increases\n   - Manufacturing productivity headwinds\n\n2. However, the traditional operating margin metric may not be the most useful measure for 3M in 2022 because:\n   - There were multiple significant one-time items and special charges\n   - The company specifically discusses \"adjusted measures\" for special items\n   - These special items are separated from core operations to better reflect underlying business performance\n\n3. The company emphasizes non-GAAP measures that adjust for special items to provide a clearer picture of underlying business performance, suggesting operating margin alone doesn't tell the full story.",
        "answer": "Operating margin alone is not the most useful metric for analyzing 3M's 2022 performance due to multiple significant one-time items and special charges that distort the traditional metric. The company's adjusted measures excluding special items would provide a better indication of core operational performance."
    },
    "4": {
        "reasoning": "1. From the context, I need to analyze organic sales performance (which excludes M&A impacts) across segments.\n\n2. Looking through the content, I can only find detailed organic sales information for the Health Care segment in 2022, which shows:\n   - Some areas showed increase (separation and purification, health information systems, food safety and medical solutions)\n   - Oral care was flat\n   - Growth was impacted by COVID-related trends on elective procedures and inflationary pressures\n\n3. While the context provides some segment-level operational information, it does not provide explicit organic growth numbers for Safety and Industrial, Transportation and Electronics, or Consumer segments for 2022.\n\n4. For Health Care specifically, the text mentions it was down 2.0% in U.S. dollars, but this includes divestiture impacts (particularly from the Food Safety Division split-off).\n\n5. Given the limited segment-level organic growth data in the provided context, I cannot definitively determine which segment had the worst organic growth performance in 2022.",
        "answer": "Based on the provided context, there is insufficient information to determine which segment specifically dragged down 3M's overall growth in 2022 when excluding M&A impacts. While we know Health Care faced some challenges, we don't have comparative organic growth data for all segments."
    },
    "5": {
        "reasoning": "1. Based on the context provided, we cannot calculate the quick ratio precisely because:\n   - While we have cash, cash equivalents, and marketable securities ($4.3 billion)\n   - We don't have information about accounts receivable\n   - We don't have information about current liabilities\n\n2. However, we can assess liquidity through other indicators provided in the context:\n   - The company has $4.3 billion in cash and equivalents\n   - It has a $4.25 billion revolving credit facility (undrawn as of June 30, 2023)\n   - Strong credit ratings (A2 from Moody's and A- from S&P)\n   - EBITDA to Interest ratio of approximately 17 to 1\n   - Proven access to capital markets mentioned in the text\n\n3. Alternative liquidity indicators suggest strong position:\n   - The company has been increasing dividends for 65 consecutive years\n   - Has maintained ability to refinance debt\n   - Has significant cash flows mentioned in the text\n   - Has a well-structured debt maturity profile",
        "answer": "The quick ratio cannot be calculated from the provided information to assess liquidity. However, based on alternative metrics like strong credit ratings, significant cash position ($4.3B), undrawn credit facility ($4.25B), and high EBITDA to Interest ratio (17:1), 3M demonstrates a healthy liquidity profile."
    },
    "6": {
        "reasoning": "1. Analyzing the provided context for information about debt securities registration:\n2. Found that 3M has a \"well-known seasoned issuer\" (WKSI) shelf registration statement effective February 8, 2023, which registers an indeterminate amount of debt or equity securities for future issuance and sale\n3. Identified that 3M has a medium-term notes program (Series F) with approximately $17.6 billion of debt issued\n4. Reviewed information about commercial paper ($1.8 billion outstanding) and revolving credit facility ($4.25 billion)\n5. However, the context does not specifically state which debt securities are registered to trade on a national securities exchange\n6. Without explicit information about exchange-listed debt securities, we cannot definitively answer which specific debt securities are registered to trade on national exchanges",
        "answer": "Based on the provided context, there is insufficient information to determine which specific debt securities are registered to trade on national securities exchanges under 3M's name as of Q2 2023."
    },
    "7": {
        "reasoning": "1. Analyzing historical dividend information:\n- 3M has been paying dividends consistently since 1916 (over 100 years)\n- They have increased dividends for 65 consecutive years as of 2023\n- This demonstrates a very long-term commitment to dividend payments\n\n2. Recent dividend actions:\n- In February 2023, the Board declared a Q1 dividend of $1.50 per share\n- This represented a 1% increase from the previous rate\n- In May 2023, they maintained the same rate for Q2 at $1.50 per share\n- This equates to an annual dividend of $6.00 per share\n\n3. Financial capacity to maintain dividends:\n- The company maintains strong credit ratings (A2 from Moody's and A- from S&P)\n- They have significant ongoing cash flows and proven access to capital markets\n- Their debt covenants specifically do not restrict dividend payments\n- Their EBITDA to Interest ratio is approximately 17 to 1, indicating strong ability to service debt and maintain dividend payments",
        "answer": "Yes, 3M maintains a very stable trend of dividend distribution, demonstrated by 65 consecutive years of dividend increases and consistent quarterly payments, with the most recent being $1.50 per share in both Q1 and Q2 2023."
    },
    "8": {
        "reasoning": "1. Unfortunately, from the provided context, I cannot calculate the fixed asset turnover ratio because:\n   - While we have some financial numbers, we don't have the complete income statement showing total revenue for FY2019\n   - We don't have the balance sheet information showing PP&E (Property, Plant & Equipment) values for either 2018 or 2019\n2. The context includes some financial metrics like employee counts (9,200) and some segment-specific numbers, but not the specific revenue and PP&E figures needed for this calculation\n3. Without both the revenue figures and PP&E values, it's impossible to calculate the fixed asset turnover ratio accurately",
        "answer": "Unable to calculate the fixed asset turnover ratio due to insufficient information about FY2019 revenue and PP&E values in the provided context."
    },
    "9": {
        "reasoning": "1. After reviewing the provided context, I cannot find:\n   - Capital expenditure (capex) figures\n   - Revenue figures\n   - Cash flow statement data\n   - Statement of income data\n\n2. Without this essential financial information in the given context, it's impossible to:\n   - Calculate capital expenditure as a percentage of revenue\n   - Determine a 3-year average from 2017-2019\n\n3. The context includes some financial data about segments, advertising expenses, and goodwill, but none of the specific data needed to calculate capex as a % of revenue.",
        "answer": "Cannot be determined from the provided context as capital expenditure and revenue figures are not available."
    },
    "10": {
        "reasoning": "1. Based on the provided context, I cannot calculate the operating cash flow ratio because:\n   - While there appears to be a mention of \"CONSOLIDATED STATEMENTS OF CASH FLOWS\" in the context, the actual cash flow numbers are not provided\n   - The total current liabilities figure is not visible in the provided balance sheet excerpts\n2. Without both the cash from operations figure and the total current liabilities figure, it's impossible to calculate the operating cash flow ratio\n3. The available context only shows page headers, some narrative disclosures, and incomplete financial statement fragments that don't contain the required metrics",
        "answer": "Cannot be calculated from the provided context as both cash from operations and total current liabilities figures are not available."
    },
    "11": {
        "reasoning": "1. After reviewing the provided context carefully, I cannot find any specific income statement data or operating income figures for FY2015 and FY2016.\n\n2. The context only contains:\n   - Information about Adobe's fiscal year structure\n   - Auditor's report\n   - Discussion about Digital Media and Marketing segment performance\n   - Tax-related information\n   - Recent accounting pronouncements\n\n3. Without access to the actual income statement figures showing operating income for both years, it's impossible to calculate the year-over-year percentage change in operating income.",
        "answer": "Cannot be determined from the given context as specific operating income figures for FY2015 and FY2016 are not provided."
    },
    "12": {
        "reasoning": "1. From the provided context, I cannot find the necessary financial information to calculate the operating cash flow ratio\n2. The context provided does not contain Adobe's balance sheet or cash flow statement data for FY2017\n3. To calculate this ratio, we would need:\n   - Cash from operations (from cash flow statement)\n   - Total current liabilities (from balance sheet)\n4. Without these specific financial figures, it's impossible to calculate the operating cash flow ratio",
        "answer": "Unable to calculate the FY2017 operating cash flow ratio as the required financial data (cash from operations and total current liabilities) is not provided in the given context."
    },
    "13": {
        "reasoning": "1. Let me analyze the operating metrics from the provided context:\n- For FY2022:\n  * Total revenue growth: Adobe saw strong growth across segments\n  * Cost of revenue increased by 16% to $2.17B from $1.87B\n  * Operating expenses increased by 15% to $9.34B from $8.12B\n  * The increases in costs were primarily due to:\n    - Higher hosting services and data center costs\n    - Increases in base and incentive compensation\n    - Increased marketing spend\n\n2. Why operating margin may not be the best metric for Adobe:\n   * Adobe is a subscription-based software company (SaaS model)\n   * More relevant metrics mentioned in the context include:\n   * Digital Media ARR (Annual Recurring Revenue) - $13.97B in FY2022\n   * Remaining performance obligations - $15.19B\n   * Cash flows from operations - $7.84B (up 8%)\n\n3. Better metrics for Adobe would focus on:\n   * Recurring revenue growth\n   * ARR expansion\n   * Cash flow generation\n   * Customer retention and expansion\n   * These metrics better reflect the health of a subscription software business",
        "answer": "Operating margin is not the most useful metric for evaluating Adobe's financial performance. As a SaaS company, Adobe's business health is better measured through metrics like Annual Recurring Revenue (ARR), remaining performance obligations, and cash flow generation, which better reflect the subscription-based nature of their business model and long-term value creation potential."
    },
    "14": {
        "reasoning": "1. To determine free cash flow conversion trend, I need to analyze:\n   - Operating cash flow trends\n   - Cash flow conversion metrics (operating cash flow to net income ratio)\n\n2. From the context provided:\n   - Cash flows from operations in FY2022 were $7.84 billion, up 8% from $7.23 billion in FY2021\n   - The increase was \"primarily due to higher net income after adjustment for non-cash items\"\n   - However, the context doesn't provide complete net income figures or detailed cash flow statements\n\n3. Limitations in analysis:\n   - Cannot calculate exact free cash flow conversion ratio without:\n     * Complete net income figures\n     * Capital expenditure data\n     * Multiple years of cash flow data for trend analysis\n\n4. While operating cash flow showed improvement, this alone is insufficient to definitively conclude about free cash flow conversion trends without more complete financial data.",
        "answer": "Unable to definitively determine Adobe's free cash flow conversion trend for FY2022 due to insufficient information about net income figures and capital expenditures in the provided context."
    },
    "15": {
        "reasoning": "1. I reviewed the income statement data provided in the context, particularly looking at the detailed breakdown of costs and expenses for FY2022\n2. Analyzed all line items in the income statement sections shown in pages 130 and 82\n3. Searched for any explicit mention of \"restructuring costs\" or similar terms in the financial data\n4. Found that while there are various expense categories listed (such as operating costs, general and administrative expenses, interest expense, etc.), there is no explicit line item for restructuring costs\n5. Since the question asks to state 0 if restructuring costs are not explicitly outlined, and no such costs are directly shown in the income statement data provided",
        "answer": "0"
    },
    "16": {
        "reasoning": "1. Looking through the provided context, I notice there is no explicit mention of inventory or inventory-related metrics in any of the financial statements or notes\n2. The context shows AES Corporation's financial statements which include revenue, cost of sales, and other major line items, but notably absent is any inventory line item\n3. This makes sense because AES Corporation is primarily an energy and power company that:\n   - Generates and distributes electricity\n   - Has both regulated and non-regulated operations\n   - Deals primarily in services and power generation rather than physical goods\n4. For utility and power companies like AES, conventional inventory management metrics like inventory turnover are not meaningful because:\n   - Their primary \"product\" (electricity) cannot be stored as traditional inventory\n   - They operate on a real-time generation and distribution model\n   - Their business model is service-based rather than inventory-based",
        "answer": "Inventory turnover ratio calculation is not meaningful for AES Corporation because as a power generation and utility company, they do not maintain significant conventional inventory. Their primary product (electricity) is generated and distributed in real-time rather than stored as inventory."
    },
    "17": {
        "reasoning": "1. First, I need to identify the key financial metrics:\n- FY2022 Net Income (Loss): $(546) million\n- Total Assets FY2022: $38,363 million\n- Total Assets FY2021: $32,963 million\n\n2. Calculate average total assets for FY2021-2022:\n- Average Total Assets = ($38,363M + $32,963M) / 2 = $35,663M\n\n3. Calculate Return on Assets:\n- ROA = Net Income / Average Total Assets\n- ROA = $(546)M / $35,663M\n- ROA = -0.0153 or -1.53%",
        "answer": "-1.53%"
    },
    "18": {
        "reasoning": "1. Based on the provided context, I cannot calculate the DPO directly because:\n   - The context does not contain the actual balance sheet numbers for accounts payable for 2016 and 2017\n   - The context does not contain complete P&L statement information\n   - The context does not show inventory balances for 2016 and 2017\n\n2. However, the context does provide some relevant qualitative information about Amazon's payables management:\n   - From page 17: \"On average, our high inventory velocity means we generally collect from consumers before our payments to suppliers come due\"\n   - Amazon mentions they \"expect some variability in accounts payable days over time\" due to factors like:\n     * Mix of product sales\n     * Mix of sales by third-party sellers\n     * Mix of suppliers\n     * Seasonality\n     * Changes in payment terms\n\n3. Without the actual financial statement numbers, I cannot provide the specific DPO calculation requested.",
        "answer": "Unable to calculate DPO due to insufficient financial data in the provided context. The required balance sheet and P&L statement line items are not included in the given text."
    },
    "19": {
        "reasoning": "1. From the financial data shown in the table on page 67:\n   - Total consolidated revenue for 2016: $135,987 million\n   - Total consolidated revenue for 2017: $177,866 million\n\n2. Calculate year-over-year change:\n   - Change = (2017 value - 2016 value) / 2016 value \u00d7 100\n   - Change = ($177,866M - $135,987M) / $135,987M \u00d7 100\n   - Change = $41,879M / $135,987M \u00d7 100\n   - Change = 30.795%\n\n3. Rounding to one decimal place:\n   - 30.795% rounds to 30.8%\n\n4. Cross-validation: This aligns with the narrative in the context which mentions that Amazon experienced strong growth across segments in 2017, including:\n   - North America sales increased 33%\n   - International sales increased 23%\n   - AWS sales increased 43%",
        "answer": "30.8%"
    },
    "20": {
        "reasoning": "1 - Looking at the Consolidated Statements of Operations table from the context\n2 - Locate the \"Net income\" row for fiscal year 2019\n3 - Net income for 2019 is clearly stated as $11,588 million\n4 - Since there's no mention of non-controlling interests or other deductions from net income in the income statement, the full $11,588 million is attributable to shareholders",
        "answer": "$11,588 million"
    },
    "21": {
        "reasoning": "1. After reviewing the provided context, specifically looking for balance sheet information, I notice that accounts receivable (AR) is not explicitly shown in the selected financial data table or other provided excerpts.\n\n2. The balance sheet data shown only includes high-level items:\n   - Cash and cash equivalents\n   - Total assets\n   - Total debt\n   - Total shareholders' equity\n\n3. Without specific accounts receivable information being presented in the given context, I cannot provide an accurate figure for net AR.\n\n4. As a financial analyst, I must acknowledge that this data point is not available in the provided financial information.",
        "answer": "Unable to determine net accounts receivable as this information is not presented in the provided balance sheet data."
    },
    "22": {
        "reasoning": "1. Analyzing the key components of the 8-K filing:\n   - The filing primarily discusses supplemental indentures and changes in issuer entities\n   - Two main supplemental indentures were executed on June 30, 2022\n\n2. Key changes identified:\n   - A Second Supplemental Indenture for the 2016 Indenture\n   - A First Supplemental Indenture for the 2019 Indenture\n   - Both involve substitution of issuers from Amcor Finance (USA), Inc. (Former Issuer) to Amcor Flexibles North America, Inc. (Substitute Issuer)\n\n3. Affected securities:\n   - 3.625% Guaranteed Senior Notes due 2026\n   - 4.500% Guaranteed Senior Notes due 2028\n   - Both existing notes and new notes (issued in 2019) are affected\n\n4. Primary purpose:\n   The main agenda was to document and execute the substitution of the issuer entity and the assumption of covenants by the new issuer for both sets of senior notes.",
        "answer": "The key agenda of AMCOR's 8-K filing dated July 1, 2022, was to report the execution of two supplemental indentures that facilitated the substitution of Amcor Finance (USA), Inc. with Amcor Flexibles North America, Inc. as the issuer of certain senior notes, with the new issuer assuming all related covenants under the indentures."
    },
    "23": {
        "reasoning": "1. Looking at the provided context, I notice that there is no balance sheet information provided that would allow calculation of the quick ratio (which requires current assets minus inventory, divided by current liabilities).\n\n2. Analyzing the context shows this is a packaging company (Amcor) that:\n   - Is a global leader in developing and producing responsible packaging\n   - Generated $14.7 billion in sales\n   - Has operations across 218 locations in over 40 countries\n   - Deals with physical products and manufacturing\n\n3. For a manufacturing and packaging company like Amcor:\n   - Working capital and inventory management are more relevant metrics\n   - Operating cash flow and EBITDA would be key metrics\n   - Debt coverage ratios would be important given their capital-intensive nature\n   - Quick ratio would be less relevant as maintaining healthy inventory levels is crucial for their business model",
        "answer": "The quick ratio is not a primary metric that financial analysts would typically focus on for a manufacturing and packaging company like Amcor. For such companies, metrics related to operating cash flow, EBITDA, working capital management, and debt coverage are more relevant due to the capital-intensive nature of the business and the importance of maintaining appropriate inventory levels."
    },
    "24": {
        "reasoning": "1. Analyzed the provided context carefully searching for mentions of acquisitions\n2. Reviewed financial statements and narratives, particularly looking for:\n   - Business combinations\n   - Changes in intangible assets\n   - References to acquired companies\n3. Found only indirect reference to acquisitions through \"amortization of acquired intangible assets from business combinations\" line item\n4. No specific acquisitions are explicitly mentioned in any of the provided context for FY2023, FY2022, or FY2021\n5. Without explicit mention of acquisitions in the given context, cannot make claims about specific acquisitions that may have occurred",
        "answer": "Based on the provided context, there is no explicit mention of any major acquisitions made by AMCOR during FY2023, FY2022, or FY2021."
    },
    "25": {
        "reasoning": "1. From the context, specifically in Note 1 - Business Description, Amcor is described as \"a global leader in developing and producing responsible packaging\"\n\n2. Their business segments are organized into:\n   - Flexibles\n   - Rigid Packaging\n\n3. The company produces:\n   - Flexible packaging\n   - Rigid packaging containers\n   - Specialty cartons\n   - Closures\n\n4. Their main end markets include:\n   - Food\n   - Beverage\n   - Pharmaceutical\n   - Medical devices\n   - Home and personal care\n   - Other consumer goods\n\n5. Their portfolio focuses specifically on \"primary packaging for fast-moving consumer goods\" as mentioned in their \"Focused portfolio\" section",
        "answer": "Amcor primarily operates in the packaging industry, specifically focusing on producing packaging solutions for consumer goods and healthcare products."
    },
    "26": {
        "reasoning": "1. Let me analyze gross margins from the financial data:\n- FY2023: $2,725M/$14,694M = 18.5% gross margin\n- FY2022: $2,820M/$14,544M = 19.4% gross margin\n- FY2021: $2,732M/$12,861M = 21.2% gross margin\n\n2. Additional context analysis:\n- The company mentions significant raw material cost pass-through ($776M in FY2023)\n- They note experiencing \"intermittent supply shortages and price volatility of certain resins and raw materials\"\n- There are inflation impacts on energy, fuel, and labor costs\n- The company works to recover higher raw material costs but notes there can be timing lags\n\n3. Evaluation of metric usefulness:\n- Due to raw material cost pass-through mechanisms, gross margin may not be the most useful metric\n- The business model involves passing through commodity costs to customers\n- This can distort margin percentages even when the absolute dollar profit remains stable",
        "answer": "No, AMCOR does not have an improving gross margin profile, with margins declining from 21.2% in FY2021 to 18.5% in FY2023. However, gross margin is not the most useful metric for AMCOR due to their business model of passing through raw material costs to customers. This pass-through mechanism can distort margin percentages even when the underlying business performance remains stable. A better focus would be on absolute gross profit dollars and adjusted EBIT, which better reflect the company's operational performance."
    },
    "27": {
        "reasoning": "1. After reviewing the provided context carefully, I cannot find any specific information about AMCOR's restructuring liability as of Q2 FY2023.\n\n2. While the context includes:\n   - Balance sheet information\n   - Information about various liabilities\n   - Details about subsequent events and business operations\n   - Information about challenges like raw material costs, inflation, and supply chain issues\n   \n3. There is no explicit mention of any restructuring liability or related activities in the provided text excerpts.\n\n4. Therefore, I cannot provide specific details about the nature and purpose of any restructuring liability for this period.",
        "answer": "Based on the provided context, there is insufficient information to determine the nature and purpose of AMCOR's restructuring liability as of Q2 FY2023."
    },
    "28": {
        "reasoning": "1. Reviewing the provided context, I don't see a direct mention of Adjusted EBITDA for FY 2023\n2. While the context mentions several financial metrics including:\n   - Adjusted EBIT of $1,608 million\n   - GAAP Net Income of $1,048 million\n   - Net interest expense of $259 million\n   - Tax expense details\n3. The specific Adjusted EBITDA figure is not provided in the context\n4. Without the depreciation and amortization figures, we cannot calculate the EBITDA from the given information",
        "answer": "The Adjusted EBITDA figure for FY 2023 is not provided in the given context."
    },
    "29": {
        "reasoning": "1 - From the components of Fiscal 2023 Net Sales growth table, I'll identify all adjustments needed:\n- Reported Growth: +1%\n- FX impact: -3%\n- Raw Material Pass Through impact: +5%\n- Items affecting comparability: -1%\n\n2 - To get the real underlying sales growth:\n- Start with Reported Growth: +1%\n- Remove FX impact by adding back -3% = +4% (Constant Currency Growth)\n- Remove Raw Material Pass Through impact of +5% = -1%\n- Remove Items affecting comparability -1% = 0%\n\n3 - After removing all these impacts, we can see from the table that this breaks down into:\n- Volume: -3%\n- Price/Mix: +3%\nNet effect = 0% real change",
        "answer": "The real underlying sales change was 0% (flat) in FY2023 vs FY2022, consisting of -3% volume decline offset by +3% price/mix improvement."
    },
    "30": {
        "reasoning": "1. After reviewing the provided context carefully, I cannot find the actual P&L statement or statement of cash flows in the given text.\n\n2. Without access to the specific cash flow statement numbers showing depreciation and amortization, and without the complete P&L statement showing revenue figures, I cannot calculate the D&A margin percentage.\n\n3. While the context shows that AMD's 2015 revenue was approximately $4.0 billion, we do not have the specific D&A figure to calculate the margin.\n\n4. Making assumptions or using incomplete data would lead to inaccurate analysis, so it's better to acknowledge that this specific calculation cannot be made with the given information.",
        "answer": "Unable to calculate FY2015 D&A margin as the cash flow statement and detailed P&L statement are not provided in the given context. While we know 2015 revenue was $4.0 billion, the D&A figure is not available."
    },
    "31": {
        "reasoning": "1. Based on the provided context, I cannot calculate AMD's quick ratio for FY22 because:\n   - The context does not provide complete balance sheet information\n   - Specifically, we're missing current assets (cash + accounts receivable + marketable securities) and current liabilities data\n   \n2. However, we can assess some liquidity aspects from the available information:\n   - Cash, cash equivalents and short-term investments were $5.9 billion as of December 31, 2022\n   - The company has access to a $3.0 billion revolving credit facility (unused as of Dec 2022)\n   - They have a commercial paper program with a $3.0 billion limit (no outstanding balance as of Dec 2022)\n   \n3. Without the complete balance sheet data to calculate the quick ratio, it would not be appropriate to make a definitive assessment of AMD's liquidity profile using this metric specifically.\n\n4. The quick ratio is a relevant liquidity measure, but we need more data to calculate it properly.",
        "answer": "Cannot determine AMD's liquidity profile using the quick ratio as the provided context lacks complete balance sheet information including current assets and current liabilities. However, the company appears to have significant cash reserves ($5.9B) and access to additional liquidity through credit facilities."
    },
    "32": {
        "reasoning": "1. From the context, I can identify AMD's major product categories from several sections:\n\n2. Main product categories include:\n   - Server products: CPUs, GPUs, DPUs, FPGAs, and Adaptive SoC products for data centers\n   - Personal Computing products: CPUs, APUs (integrated CPU+GPU), and chipsets for desktop/notebook\n   - Graphics products: Discrete GPUs and semi-custom SoC products\n   - Embedded products: CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products\n\n3. Specific branded product lines include:\n   - Client processors: AMD Ryzen, Ryzen PRO, Threadripper, Athlon series\n   - Graphics: AMD Radeon, Radeon PRO, Radeon Instinct\n   - Server: AMD EPYC processors\n   - FPGA products: Virtex, Kintex, Artix, Spartan series\n   - Adaptive SoCs: Zynq series, Versal series\n   - Acceleration boards: Alveo brand\n\n4. Additional services:\n   - Development services\n   - Licensing of intellectual property (IP) portfolio\n   - Software platforms and solutions",
        "answer": "AMD's major products and services include: server processors (CPUs, GPUs, DPUs, FPGAs, Adaptive SoCs), personal computing products (CPUs, APUs, chipsets), graphics products (discrete GPUs, semi-custom SoCs), embedded processors, development services, and intellectual property licensing. Key brands include Ryzen, EPYC, Radeon, Threadripper, Virtex, Zynq, Versal, and Alveo."
    },
    "33": {
        "reasoning": "1. Analyzing the 2022 financial results from the context:\n- Total net revenue for 2022 was $23.6 billion\n- This represents a 44% increase from 2021's $16.4 billion\n\n2. Breaking down the revenue changes by segment:\n- Data Center: 64% increase due to higher sales of EPYC server processors\n- Gaming: 21% increase primarily from higher semi-custom product sales\n- Embedded: Significant increase driven by inclusion of Xilinx embedded product sales\n- Client: 10% decrease due to lower processor shipments in weak PC market\n\n3. Key factors affecting revenue:\n- Strategic acquisition of Xilinx in February 2022 contributed to embedded segment growth\n- Strong data center performance driven by EPYC processor sales\n- Gaming segment benefited from semi-custom products\n- Client segment faced headwinds from weak PC market and inventory corrections",
        "answer": "AMD's 44% revenue growth in FY22 was primarily driven by a 64% increase in Data Center segment revenue from EPYC processor sales, 21% growth in Gaming segment from semi-custom products, and significant Embedded segment growth from the Xilinx acquisition, partially offset by a 10% decrease in Client segment revenue due to weak PC market conditions."
    },
    "34": {
        "reasoning": "1. First, let's identify the key financial metrics from the context:\n- Operating income for 2022: $1.3 billion\n- Operating income for 2021: $3.6 billion\n- Net revenue for 2022: $23.6 billion\n- Net revenue for 2021: $16.4 billion\n\n2. Calculate operating margins:\n- 2022 operating margin: $1.3B/$23.6B = 5.5%\n- 2021 operating margin: $3.6B/$16.4B = 22%\n\n3. Analyze the drivers of the change:\n- Primary factor was amortization of intangible assets associated with the Xilinx acquisition\n- Revenue actually grew 44% year-over-year\n- The acquisition of Xilinx and Pensando in 2022 were transformative deals that reshaped the business\n\n4. Assess metric usefulness:\n- Operating margin is still a useful metric for AMD as it shows operational efficiency\n- However, in 2022, it needs to be viewed in context of major acquisitions\n- The significant decline was largely due to accounting effects (amortization) rather than operational issues",
        "answer": "AMD's operating margin declined from 22% in 2021 to 5.5% in 2022, primarily driven by the amortization of intangible assets associated with the Xilinx acquisition. While operating margin remains a useful metric for AMD, the 2022 figures should be interpreted carefully as they reflect significant accounting impacts from transformative acquisitions rather than underlying operational performance issues."
    },
    "35": {
        "reasoning": "1. From the cash flow data provided, I can identify the following cash flows for FY22:\n- Operating activities: +$3,565 million\n- Investing activities: +$1,999 million\n- Financing activities: -$3,264 million\n\n2. Comparing these values:\n- Operating activities generated positive cash flow of $3,565M\n- Investing activities generated positive cash flow of $1,999M\n- Financing activities lost cash flow of $3,264M\n\n3. Ranking from highest to lowest:\n1. Operating activities (+$3,565M)\n2. Investing activities (+$1,999M)\n3. Financing activities (-$3,264M)",
        "answer": "Operating activities brought in the most cash flow at $3,565 million in FY22."
    },
    "36": {
        "reasoning": "1. Need to identify sales changes from 2021 to 2022 across AMD's segments (excluding Embedded)\n2. From the context, AMD's segments are:\n   - Data Center\n   - Client\n   - Gaming\n   - Embedded (to be excluded)\n\n3. Looking at the sales data from the overview section:\n   - Data Center: 64% increase\n   - Client: 10% decrease\n   - Gaming: 21% increase\n   - Embedded: significant increase (excluded from analysis)\n\n4. Comparing the percentage increases:\n   - Data Center: +64%\n   - Client: -10%\n   - Gaming: +21%\n\n5. Therefore, the Data Center segment had the highest proportional increase at 64%",
        "answer": "The Data Center segment had the highest proportional increase in sales from FY21 to FY22, with a 64% increase."
    },
    "37": {
        "reasoning": "1. Searching through the provided context for information about customer concentration, I find two relevant pieces:\n\n2. From page 2 (AMD_2022_10K.pdf_page_2): There is a forward-looking statement mentioning that \"a small number of customers will continue to account for a substantial part of AMD's revenue in the future\"\n\n3. From page 12 (AMD_2022_10K.pdf_page_12): While specific customer concentration numbers are not provided for FY22, there is a mention of \"semi-custom SoC products\" having \"more stringent\" orders and agreements resulting in meaningful backlog.\n\n4. Looking at the segment revenue breakdown:\n- Data Center: $6.0 billion\n- Client: $6.2 billion\n- Gaming: $6.8 billion (includes semi-custom products for gaming consoles)\n\n5. While exact customer concentration percentages are not provided in the given context, the forward-looking statement suggests that AMD does have customer concentration.",
        "answer": "While the exact customer concentration figures are not disclosed in the provided context, AMD acknowledges in their forward-looking statements that a small number of customers will continue to account for a substantial part of their revenue."
    },
    "38": {
        "reasoning": "1. Analyzing the provided context to identify securities trading information:\n- From the context, only one security is explicitly mentioned as being listed on a national securities exchange\n- This information is found in the trading symbol section which shows \"Common Shares (par value $0.20 per Share) AXP New York Stock Exchange\"\n\n2. Reviewing debt securities information:\n- While the context shows various debt securities (Fixed Rate Senior Notes, Floating Rate Senior Notes, etc.)\n- None of these debt securities are explicitly mentioned as being registered to trade on any national securities exchange\n- The debt securities information primarily appears in the context of the company's balance sheet and financial obligations\n\n3. Conclusion:\n- Based on the provided context, there is no explicit mention of any debt securities being registered to trade on a national securities exchange\n- The only registered security mentioned is the common stock (AXP)",
        "answer": "Based on the provided context, there is no indication of any debt securities being registered to trade on a national securities exchange. The only security explicitly mentioned as exchange-traded is American Express' common stock (AXP) on the New York Stock Exchange."
    },
    "39": {
        "reasoning": "1. Analyzing the geographical information from the context:\n- American Express operates a payments network in approximately 103 countries and territories\n- The company has approximately 77,300 employees with:\n  * 26,000 colleagues in the United States\n  * 51,300 colleagues outside the United States\n\n2. Key geographic concentrations mentioned:\n- United States is the primary market (with ~80% of unused credit being related to U.S. customers)\n- Largest concentrations outside the United States include:\n  * United Kingdom\n  * Japan\n  * European Union\n  * Australia\n  * Canada\n  * Mexico\n\n3. Strategic partnerships and operations:\n- Has joint ventures in specific regions:\n  * China\n  * Middle East\n  * Switzerland",
        "answer": "American Express primarily operates in the United States, which is its largest market, with significant presence in the United Kingdom, Japan, European Union, Australia, Canada, and Mexico. The company maintains operations across approximately 103 countries and territories globally, with strategic joint ventures in China, the Middle East, and Switzerland."
    },
    "40": {
        "reasoning": "1. Operating margin is typically calculated as operating income divided by revenue, showing how efficiently a company manages its operations.\n\n2. However, for financial services companies like American Express, traditional operating margin is not a particularly useful metric because:\n   - Their business model is fundamentally different from traditional product/service companies\n   - Revenue includes interest income and credit-related earnings\n   - Expenses are heavily influenced by Card Member rewards, credit losses, and provisions\n   \n3. From the context, we can see AMEX's key performance metrics are more focused on:\n   - Credit metrics and loan performance\n   - Card Member spending volumes\n   - Return on Equity (ROE)\n   - Capital ratios (like Common Equity Tier 1 ratio of 10.3%)\n   - Customer acquisition and engagement metrics\n   \n4. The 2022 context shows AMEX focuses on metrics like:\n   - Net income ($7.5B in 2022 vs $8.1B in 2021)\n   - Credit reserve levels\n   - Card Member rewards and service expenses\n   - Network volumes and merchant coverage",
        "answer": "Operating margin is not a particularly useful metric for analyzing American Express. As a financial services company, AMEX's performance is better evaluated through metrics like return on equity (ROE), credit quality metrics, capital ratios, and revenue growth from card spending volumes. The company's profitability is more dependent on its ability to manage credit risk, maintain strong capital positions, and grow its card member base rather than traditional operating efficiency metrics."
    },
    "41": {
        "reasoning": "1. Analyzing the context provided, I note that gross margin is not directly discussed in the given text\n2. This makes sense because American Express is a financial services company, not a traditional product-based company\n3. For financial services companies like American Express:\n   - Revenue comes primarily from discount fees from merchants, card member fees, and interest income\n   - Traditional \"cost of goods sold\" doesn't exist in the same way as manufacturing companies\n   - Key metrics are instead focused on:\n     * Discount rates (fee charged to merchants)\n     * Net interest income\n     * Credit performance\n     * Operating expenses\n     * Capital ratios\n4. From the context, we can see AmEx focuses on metrics like:\n   - Billed business ($1,338 billion in 2022)\n   - Cards-in-force (76.7 million proprietary cards)\n   - Various capital ratios that indicate financial health\n   - Credit performance and reserve levels",
        "answer": "Gross margin is not a relevant metric for American Express. As a financial services company, AmEx's profitability is better measured through metrics like net interest margin, discount revenue, and operating efficiency ratios, rather than gross margin which is more applicable to companies that sell physical products with direct cost of goods sold."
    },
    "42": {
        "reasoning": "1. Located the effective tax rate information in the provided context:\n   - For FY2022: 21.6%\n   - For FY2021: 24.6%\n\n2. Calculated the change:\n   - Decrease from 24.6% to 21.6%\n   - Total decrease of 3 percentage points\n\n3. Found supporting explanation in context:\n   - The reduction was primarily due to discrete benefits in 2022 related to the resolution of prior-year tax items\n   - Tax rates in both years reflected the level of pretax income in relation to recurring permanent tax benefits and geographic mix of business",
        "answer": "The effective tax rate decreased by 3 percentage points, from 24.6% in FY2021 to 21.6% in FY2022."
    },
    "43": {
        "reasoning": "1. From the context, I can identify the major liability categories from the balance sheet:\n- Customer deposits: $110,239 million\n- Accounts payable: $12,133 million\n- Short-term borrowings: $1,348 million\n- Long-term debt: $42,573 million\n- Other liabilities: $37,350 million\n\n2. Comparing these values:\n$110,239M > $42,573M > $37,350M > $12,133M > $1,348M\n\n3. Customer deposits is clearly the largest liability item at $110,239 million in 2022.",
        "answer": "Customer deposits was the largest liability at $110,239 million in 2022."
    },
    "44": {
        "reasoning": "1. From the context, I can identify key information about card member retention:\n- Net card fees increased 17% year-over-year\n- The document specifically mentions \"Card Member retention remained high\"\n- New card acquisitions reached record levels in 2022\n- The company demonstrated \"continued ability to acquire, engage and retain high-spending, premium Card Members\"\n\n2. This information suggests strong retention because:\n- Growing card fees while maintaining high retention indicates customers see value in keeping their cards\n- Record new acquisitions combined with high retention indicates overall growth in the card member base\n- The emphasis on \"premium\" card members suggests quality retention of valuable customers\n\n3. The company's success in retention appears to be attributed to:\n- Investments made in premium value propositions\n- Strong spending volumes throughout 2022\n- Providing value and unique experiences across customer base",
        "answer": "Yes, American Express had strong card member retention in 2022, with retention rates remaining high while also achieving record levels of new card acquisitions."
    },
    "45": {
        "reasoning": "1. From the provided context, specifically looking for dividend payment information\n2. Found explicit statement: \"During 2020, 2019 and 2018, the Company paid $389 million, $353 million and $319 million in cash dividends, respectively.\"\n3. Need to convert $389 million to billions\n4. Calculation: $389 million = $0.389 billion",
        "answer": "0.389"
    },
    "46": {
        "reasoning": "1. After reviewing the provided context, I cannot definitively calculate American Water Works's FY2021 unadjusted EBITDA because:\n- The cash flow statement is not included in the provided context\n- The income statement is not included in the provided context\n- While there are references to operating revenues increasing by $129 million and some other financial details, we don't have the base numbers needed to calculate EBITDA\n\n2. To calculate unadjusted EBITDA, we would need:\n- Operating income from the income statement\n- Depreciation and amortization from the cash flow statement\nNeither of these key components are provided in the context.\n\n3. While there are mentions of financial metrics and accounting principles, none provide the specific numbers needed for this calculation.",
        "answer": "Cannot be determined from the provided context as the cash flow statement and income statement are not included in the given information."
    },
    "47": {
        "reasoning": "1. After reviewing the provided context, I notice that:\n- While there are mentions of \"working capital\" in the text, it only appears in reference to \"changes in working capital\" in the cash flow discussions\n- The context doesn't provide the actual current assets and current liabilities figures that would be needed to calculate working capital\n- The context includes portions of the 10-K including auditor's report, some exhibits, and cash flow discussions, but not the detailed balance sheet information needed\n\n2. Without access to the complete balance sheet data showing current assets and current liabilities, it's impossible to definitively calculate working capital for FY2022.\n\n3. However, there's an important observation about working capital for utility companies:\n- Utilities like American Water Works typically maintain lower levels of working capital than other industries\n- This is because they have steady, regulated cash flows from providing essential services\n- They can often operate effectively with negative working capital due to their business model of collecting from customers before paying their obligations",
        "answer": "Based on the provided context, we cannot determine American Water Works' specific working capital position for FY2022 due to missing balance sheet data. However, working capital is generally not considered a critical metric for regulated utility companies like American Water Works due to their predictable cash flows and unique business model."
    },
    "48": {
        "reasoning": "1. First, I need to identify net earnings and revenue for each year (2015-2017):\n- 2017: Net earnings = $1,228M, Revenue = $39,403M\n- 2016: Net earnings = $897M, Revenue = $39,528M\n- 2015: Net earnings = $1,233M, Revenue = $40,339M\n\n2. Calculate net profit margin for each year:\n- 2017: ($1,228M / $39,403M) \u00d7 100 = 3.12%\n- 2016: ($897M / $39,528M) \u00d7 100 = 2.27%\n- 2015: ($1,233M / $40,339M) \u00d7 100 = 3.06%\n\n3. Calculate the 3-year average:\n(3.12% + 2.27% + 3.06%) \u00f7 3 = 2.82%\n\n4. Round to one decimal place:\n2.82% rounds to 2.8%",
        "answer": "2.8%"
    },
    "49": {
        "reasoning": "1. Looking at the balance sheet data in the context\n2. Located the line item \"Merchandise inventories\" under Current Assets\n3. For FY2019, merchandise inventories amount is shown as $5,409 million\n4. This represents the year-end inventory value for Best Buy in fiscal year 2019\n5. No adjustments or calculations needed as the value is directly stated in the balance sheet",
        "answer": "5,409"
    },
    "50": {
        "reasoning": "1. Analyzing the provided context, I cannot find any specific gross margin data or historical gross margin trends in the given text excerpts.\n\n2. While gross margins would be a highly relevant metric for Best Buy as a retail company because:\n   - It shows their pricing power\n   - It indicates their ability to manage cost of goods sold\n   - It's particularly important for electronics retailers who face intense price competition\n\n3. The context does include relevant information about Best Buy's business model and competitive environment that suggests margins are important:\n   - They mention \"maintaining price competitiveness is one of our ongoing priorities\"\n   - They have price-matching policies\n   - They face competition from companies with \"lower cost operating structures\"\n\n4. However, without actual gross margin numbers from multiple years, I cannot make a determination about the historical consistency of their gross margins.",
        "answer": "Cannot determine gross margin consistency from the provided context. While gross margins are a very relevant metric for a retail company like Best Buy, the text excerpts do not contain the historical gross margin data needed to assess their consistency."
    },
    "51": {
        "reasoning": "1. Reviewing the context for acquisition information across fiscal years:\n- The acquisitions information is primarily found in section \"2. Acquisitions\" of the 10-K\n- The context specifically mentions two acquisitions in fiscal 2022\n- No acquisitions are explicitly mentioned for fiscal 2023 or fiscal 2021\n\n2. Analyzing the fiscal 2022 acquisitions:\na) Current Health Ltd.\n- Acquired on November 2, 2021\n- Purchase price: $389 million net cash\n- A care-at-home technology platform\n- Included $351 million of goodwill\n- Part of Best Buy Health reporting unit\n\nb) Yardbird Furniture (Two Peaks, LLC)\n- Acquired on November 4, 2021\n- Purchase price: $79 million net cash\n- A direct-to-consumer outdoor furniture company\n- Included $47 million of goodwill\n- Part of Best Buy Domestic reporting unit\n\n3. Confirmation of timeline:\n- Both acquisitions occurred in fiscal 2022\n- No explicit mention of any acquisitions in fiscal 2023 or fiscal 2021 in the provided context",
        "answer": "In fiscal 2022, Best Buy made two major acquisitions: Current Health Ltd. (for $389 million) and Yardbird Furniture (for $79 million). No major acquisitions were mentioned for fiscal 2023 or fiscal 2021 in the provided context."
    },
    "52": {
        "reasoning": "1. Looking at the cash flow data for FY2023 (ending January 28, 2023), let's analyze each category:\n\n2. Operating Activities:\n   - Total cash provided by operating activities = $1,824 million (positive)\n\n3. Investing Activities:\n   - Total cash used in investing activities = $(962) million (negative)\n\n4. Financing Activities:\n   - Total cash used in financing activities = $(1,806) million (negative)\n\n5. Comparing the three:\n   - Operating: +$1,824 million\n   - Investing: -$962 million\n   - Financing: -$1,806 million\n\n6. Operating activities is the only positive cash flow and therefore brought in the most cash (or lost the least) among the three categories.",
        "answer": "Operating activities brought in the most cash flow in FY2023 with a positive $1,824 million, while both investing and financing activities had negative cash flows."
    },
    "53": {
        "reasoning": "1. Reviewing the provided context carefully, I notice there's actually no explicit comparative data shown for Cash & Cash equivalents between FY 2023 and Q2 FY2024.\n\n2. While the context mentions \"Cash and cash equivalents were as follows ($ in millions):\" on page 18, the actual table with values is not included in the provided excerpts.\n\n3. The context does discuss cash flows in various activities:\n   - There was an increase in cash from operating activities\n   - Decrease in cash used in investing activities\n   - Decrease in cash used in financing activities\n   But these movements don't directly tell us the ending cash balance comparison.\n\n4. Without the specific cash balance numbers, I cannot definitively state whether there was a drop in Cash & Cash equivalents between these periods.",
        "answer": "Based on the provided context, I cannot determine if there was a drop in Cash & Cash equivalents between FY 2023 and Q2 of FY2024 as the specific cash balance numbers are not included in the given excerpts."
    },
    "54": {
        "reasoning": "1. Analyzing store count data from the context:\n- For Canada Best Buy stores:\n  * FY2023 Q2: Started with 127 stores, no changes, ended with 127 stores\n  * FY2024 Q2: Started with 127 stores, opened 1 store, ended with 128 stores\n\n2. Analyzing Best Buy Mobile stores:\n  * FY2023 Q2: Started with 33 stores, no changes, ended with 33 stores\n  * FY2024 Q2: Started with 32 stores, no changes, ended with 32 stores\n\n3. Calculating total net change:\n  * FY2024 Q2 ended with 128 regular stores + 32 mobile stores = 160 total\n  * FY2023 Q2 ended with 127 regular stores + 33 mobile stores = 160 total",
        "answer": "Yes, there was a change in store composition but no change in total store count. FY2024 had one more regular Best Buy store and one fewer mobile store compared to FY2023, keeping the total at 160 stores in both periods."
    },
    "55": {
        "reasoning": "1. Analyzed the provided context for domestic revenue/sales performance by product category\n2. The context does not contain specific product category performance data or revenue breakdown for Q2 FY2024\n3. While the context discusses store counts and planned store changes, it does not provide the sales performance by product category that would be needed to determine which category performed best",
        "answer": "Cannot determine from the given context. While the document mentions that there is a \"revenue mix percentage and comparable sales percentage changes by revenue category,\" the actual category performance data is not provided in the given excerpt."
    },
    "56": {
        "reasoning": "1. From the context, I cannot directly calculate the working capital ratio because:\n   - While we have the working capital amount ($423,961,000 for 2016)\n   - We don't have a complete breakdown of all current assets and current liabilities\n   - Only some current items are shown: cash & equivalents, settlements receivable (assets) and customers payable (liabilities)\n2. Without the complete current assets and current liabilities figures, we cannot accurately calculate the working capital ratio\n3. The data available is insufficient to provide the requested ratio calculation.",
        "answer": "Cannot be calculated from the provided data. While working capital amount is shown as $423,961,000, the complete current assets and current liabilities figures needed for the ratio calculation are not provided in the context."
    },
    "57": {
        "reasoning": "1. From the context, specifically examining page 60, I can find the revenue growth information:\n\"Total net revenue for the year ended December 31, 2020, increased by $4.8 billion, or 101%, compared to the year ended December 31, 2019.\"\n\n2. The growth rate is explicitly stated as 101% year-over-year from FY2019 to FY2020.\n\n3. As an investment banking analyst looking at this information:\n   - The growth rate is directly stated in the text\n   - No additional calculations are needed\n   - The number is already in percentage format\n   - It's already rounded to a whole number, which meets the one decimal place requirement\n\n4. Therefore, the year-over-year revenue growth rate from FY2019 to FY2020 was 101.0%",
        "answer": "101.0%"
    },
    "58": {
        "reasoning": "1 - Looking at the cash flow statement data in the context, I can locate the \"Net cash provided by operating activities\" line item\n2 - For fiscal year 2020, the amount shown is $381,603 (in thousands)\n3 - To convert from thousands to millions, I need to divide by 1,000\n4 - $381,603 thousands = $381.603 millions\n",
        "answer": "$381.6 million"
    },
    "59": {
        "reasoning": "1. Looking through the provided context carefully for balance sheet information.\n2. Notice that page 49 mentions \"Consolidated Statements of Financial Position\" (which is another term for balance sheet).\n3. However, the actual balance sheet figures showing Property, Plant & Equipment (PPE) are not provided in the given context.\n4. While there are various financial figures shown (revenue segments, investments, etc.), none specifically show the net PPE value.\n5. Therefore, we cannot determine the exact net PPE value from the provided context alone.",
        "answer": "Cannot be determined from the provided context. While the document mentions a Consolidated Statement of Financial Position, the specific net PPE figure for FY2018 is not shown in the given excerpts."
    },
    "60": {
        "reasoning": "1. First, let's identify Boeing's total revenue for FY2022:\n- Total revenue = $66,608 million\n\n2. Calculate the revenue percentage for each major segment:\n- Commercial Airplanes: $25,867M / $66,608M = 38.8%\n- Defense, Space & Security: $23,162M / $66,608M = 34.8%\n- Global Services: $17,611M / $66,608M = 26.4%\n- Boeing Capital: $199M / $66,608M = 0.3%\n- Unallocated items: ($231M) / $66,608M = -0.3%\n\n3. Identify segments exceeding 20% threshold:\n- Three major segments exceed 20% of total revenue:\n  * Commercial Airplanes (38.8%)\n  * Defense, Space & Security (34.8%)\n  * Global Services (26.4%)",
        "answer": "Yes, three categories exceed 20% of revenue in FY2022: Commercial Airplanes (38.8%), Defense, Space & Security (34.8%), and Global Services (26.4%)."
    },
    "61": {
        "reasoning": "1. Analyzing the legal proceedings section of the 10-K:\n- Boeing is involved in multiple legal proceedings\n- Two major significant legal matters are explicitly detailed:\n  a) Cases related to the 737 MAX accidents (Lion Air Flight 610 and Ethiopian Airlines Flight 302)\n  b) Arbitration with Embraer regarding terminated joint venture agreements\n\n2. Examining the 737 MAX related matters:\n- Boeing entered into a Deferred Prosecution Agreement with the U.S. Department of Justice\n- Settled with shareholders derivative lawsuit ($219M received in Q2 2022)\n- Settled SEC investigation with $200M civil penalty paid in October 2022\n- Still facing pending lawsuits with unquantifiable potential losses\n\n3. Analyzing the Embraer dispute:\n- Involves a terminated $4.2B deal for 80% ownership of Embraer's commercial operations\n- Currently in arbitration expected to complete in late 2023 or early 2024\n- Potential losses cannot be reasonably estimated\n\n4. Materiality assessment:\n- Boeing explicitly states they cannot reasonably estimate potential losses for both major cases\n- The company acknowledges these could have material impacts\n- Both matters are ongoing and unresolved as of FY2022",
        "answer": "Yes, Boeing has two materially important ongoing legal battles in FY2022: (1) pending lawsuits related to the 737 MAX crashes with unquantifiable potential losses, and (2) an arbitration dispute with Embraer over a terminated $4.2 billion joint venture agreement, expected to conclude in late 2023 or early 2024."
    },
    "62": {
        "reasoning": "1. To analyze gross margin, first let's calculate it using (Total revenues - Cost of products - Cost of services)/Total revenues:\n\n2022:\n- Revenue: $66,608M\n- Cost of products & services: ($53,969M + $9,109M) = $63,078M\n- Gross Margin = ($66,608M - $63,078M)/$66,608M = 5.3%\n\n2021:\n- Revenue: $62,286M\n- Cost of products & services: ($49,954M + $9,283M) = $59,237M\n- Gross Margin = ($62,286M - $59,237M)/$62,286M = 4.9%\n\n2020:\n- Revenue: $58,158M\n- Cost of products & services: ($54,568M + $9,232M) = $63,800M\n- Gross Margin = ($58,158M - $63,800M)/$58,158M = -9.7%\n\n2. While gross margin has improved from -9.7% in 2020 to 5.3% in 2022, gross margin alone may not be the most useful metric for Boeing due to:\n   - High R&D costs ($2,852M in 2022)\n   - Significant G&A expenses ($4,187M in 2022)\n   - Long product development cycles\n   - Complex program accounting\n   - Mix of products and services across different segments (Commercial, Defense, Services)",
        "answer": "While Boeing's gross margin has improved from -9.7% in 2020 to 5.3% in 2022, this metric alone is not the most useful for evaluating Boeing's performance due to its complex business model involving significant R&D investments, long product development cycles, program accounting, and diverse business segments. Operating margin or program-specific margins might be more meaningful metrics."
    },
    "63": {
        "reasoning": "1 - Based on the context provided, I'll analyze Boeing's business segments and their customers:\n2 - From the context, Boeing operates in four main segments:\n   - Commercial Airplanes (BCA)\n   - Defense, Space & Security (BDS)\n   - Global Services (BGS)\n   - Boeing Capital (BCC)\n3 - For Commercial Airplanes segment, the context explicitly states they serve \"commercial airline industry worldwide\"\n4 - For Defense, Space & Security segment, the context shows they serve military customers with products like:\n   - Military aircraft\n   - Strategic defense systems\n   - Intelligence systems\n   - Government satellites\n5 - The context doesn't explicitly detail customers for Global Services and Boeing Capital segments, but we can identify the two main customer groups from the major segments",
        "answer": "Boeing's primary customers are commercial airlines worldwide and government/military customers, particularly through their Commercial Airplanes and Defense, Space & Security segments respectively."
    },
    "64": {
        "reasoning": "1. Analyzing the context, there are several key points that indicate cyclicality in Boeing's business:\n\n2. From the Risk Factors section, it's specifically stated that \"Historically, the airline industry has been cyclical and very competitive and has experienced significant profit swings\"\n\n3. Boeing's commercial aircraft business is heavily dependent on:\n   - Long-term trends in airline passenger and cargo traffic\n   - Airline profitability\n   - Economic conditions\n   - Fuel prices\n   - Market conditions\n\n4. The company notes that \"Significant deterioration in the global economic environment, the airline industry generally or the financial stability of one or more of our major customers could result in fewer new orders\"\n\n5. While Boeing itself doesn't explicitly state its overall business is seasonal (in fact states \"No material portion of our business is considered to be seasonal\"), the evidence shows clear cyclical patterns tied to economic and industry cycles",
        "answer": "Yes, Boeing's business is subject to cyclicality, particularly in its commercial aircraft segment which is heavily influenced by the cyclical nature of the airline industry and broader economic conditions, though it is not subject to seasonal fluctuations."
    },
    "65": {
        "reasoning": "1. From the context, I can identify several key production rate changes mentioned for different aircraft programs:\n\n2. For the 787 program:\n- Currently producing at low rates\n- Expected to gradually increase to 5 per month in 2023\n\n3. For the 777X program:\n- Production is currently paused\n- Expected to resume production in 2023\n- Currently producing at a combined rate of 3 per month for 777/777X programs\n\n4. For the 737 program:\n- Currently at 31 per month\n- Plans to gradually increase production rates based on market demand and supply chain capacity\n- No specific target rate mentioned for 2023\n\n5. For the 767 program:\n- Currently producing at a combined rate of 3 aircraft per month (including KC-46A Tanker)\n- No specific changes mentioned for 2023",
        "answer": "For FY2023, Boeing is forecasting: 787 production to gradually increase to 5 per month, 777X production to resume after being paused, 737 production to gradually increase from current rate of 31 per month (specific target not provided), while 767 maintains its current rate of 3 per month."
    },
    "66": {
        "reasoning": "1. From the financial data, I can identify the effective tax rates for both years:\n- FY2022: (0.6)%\n- FY2021: 14.8%\n\n2. Analyzing these figures:\n- 2022's negative tax rate of (0.6)% indicates Boeing received a small tax benefit relative to its pre-tax loss\n- 2021's positive tax rate of 14.8% indicates Boeing incurred tax expenses despite having a pre-tax loss\n\n3. Comparing the two years:\n- The effective tax rate decreased significantly by 15.4 percentage points\n- This represents a substantial change in Boeing's tax position between the two years",
        "answer": "Boeing's effective tax rate decreased significantly from 14.8% in FY2021 to (0.6)% in FY2022, a reduction of 15.4 percentage points."
    },
    "67": {
        "reasoning": "1. To calculate ROA, I need:\n- FY2017 Net Income: $1,248 million (from P&L statement)\n- FY2017 Total Assets: $87,896 million (from balance sheet)\n- FY2016 Total Assets: $87,270 million (from balance sheet)\n\n2. Calculate average total assets:\n- Average Total Assets = ($87,896 + $87,270) / 2 = $87,583 million\n\n3. Calculate Return on Assets (ROA):\n- ROA = Net Income / Average Total Assets\n- ROA = $1,248 / $87,583 = 0.0142 or 1.42%",
        "answer": "1.42%"
    },
    "68": {
        "reasoning": "1. Looking at the provided context, I cannot find any specific financial metrics or line items from the income statement showing Cost of Goods Sold (COGS) or revenue numbers for FY2021.\n\n2. While the context mentions \"CONSOLIDATED STATEMENTS OF INCOME\" on page 59, the actual financial figures are not provided in the excerpts.\n\n3. Without access to the actual income statement figures for revenue and COGS, it's impossible to calculate the COGS margin percentage (which would normally be calculated as: COGS \u00f7 Revenue \u00d7 100).\n\n4. The context only contains general company information, description of business, and references to financial statements without the actual numerical data.",
        "answer": "Cannot be calculated from the given context as the income statement line items showing revenue and COGS figures are not provided in the excerpts."
    },
    "69": {
        "reasoning": "1. From the provided context, I can find the key metrics needed from the financial data:\n   - Net income attributable to shareowners of The Coca-Cola Company (2022): $9,542 million\n   - Dividends paid in 2022: $7,617 million (shown as \"(7,617)\" with note \"per share \u2014 $1.76\")\n\n2. Calculate dividend payout ratio:\n   - Formula: (Total Cash Dividends Paid / Net Income Attributable to Shareholders) \u00d7 100\n   - Calculation: ($7,617 million / $9,542 million) \u00d7 100\n   - Result: 0.7982 \u00d7 100 = 79.82%\n\n3. Rounding to two decimal places:\n   - Final dividend payout ratio = 79.82%",
        "answer": "79.82%"
    },
    "70": {
        "reasoning": "1. While we can find the accounts payable values from the balance sheet:\n   - 2020 AP: $1,174M\n   - 2019 AP: $1,587M\n   - Average AP = ($1,174M + $1,587M)/2 = $1,380.5M\n\n2. However, we cannot calculate DPO using the formula provided because:\n   - We don't have COGS information in the given context\n   - While we can see inventory values (2020: $2,438M, 2019: $2,320M), without COGS we cannot complete the calculation\n\n3. Looking at the provided financial metrics in the context, we can see that Corning directly reports DPO:\n   - For 2020, DPO is explicitly stated as 44 days\n\n4. Since this is directly reported by the company, we should use this official figure rather than attempting to calculate with incomplete information.",
        "answer": "44.00"
    },
    "71": {
        "reasoning": "1 - From the income statements, I need to identify operating income and net sales for each year:\n\n2021:\n- Operating income: $2,112M\n- Net sales: $14,082M\n- Operating margin = (2,112/14,082) \u00d7 100 = 15.0%\n\n2020:\n- Operating income: $509M\n- Net sales: $11,303M\n- Operating margin = (509/11,303) \u00d7 100 = 4.5%\n\n2019:\n- Operating income: $1,306M\n- Net sales: $11,503M\n- Operating margin = (1,306/11,503) \u00d7 100 = 11.4%\n\n2 - Calculate 3-year average:\n(15.0% + 4.5% + 11.4%) \u00f7 3 = 10.3%",
        "answer": "10.3%"
    },
    "72": {
        "reasoning": "1. From the financial data provided, I can identify the effective tax rates for both years:\n- FY2022: 23%\n- FY2021: 20%\n\n2. To calculate the change:\n- Simple subtraction: 23% - 20% = 3% increase\n- This represents an increase of 300 basis points in the effective tax rate\n\n3. The context also provides reasons for the different tax rates:\n- 2022 had several provisions including:\n  * $67M due to tax reserves\n  * $40M due to foreign earnings differences\n  * $38M due to valuation allowance assessments\n  * Benefits of $60M from tax credits and $49M from foreign derived intangible income\n- 2021 had different factors including:\n  * Benefits of $62M from tax credits\n  * $37M benefit from share-based compensation\n  * $52M provision from foreign earnings",
        "answer": "The effective tax rate increased by 3 percentage points, from 20% in FY2021 to 23% in FY2022."
    },
    "73": {
        "reasoning": "1. From the provided context, I cannot find the necessary components to calculate working capital (current assets and current liabilities) as this information is not present in the given excerpts from Corning's 2022 10-K.\n\n2. However, I can provide insights about why working capital analysis would be relevant for Corning:\n   - The context shows Corning is a manufacturing company with significant operations\n   - They mention maintaining inventory levels and dealing with supply chain challenges\n   - They have approximately 57,500 employees and multiple manufacturing facilities\n   - They discuss managing raw materials and production costs\n\n3. Given Corning's business model as a manufacturing company:\n   - Working capital would be a highly relevant metric\n   - They need to manage inventory levels\n   - They have ongoing operational expenses\n   - They need to maintain adequate liquidity for day-to-day operations",
        "answer": "Based on the provided context, I cannot determine if Corning has positive working capital for FY2022 as the balance sheet information is not included. However, working capital is definitely a relevant metric for Corning given their manufacturing operations, inventory management needs, and global operational footprint."
    },
    "74": {
        "reasoning": "1. Looking through the provided context, I do not see a balance sheet or total assets figure presented.\n2. While there is extensive discussion of Costco's business operations, segments, and certain financial metrics in the 10-K excerpts, the actual balance sheet data is not included in the provided text.\n3. Without access to the balance sheet section of the 10-K, I cannot determine the total assets figure for FY2021.",
        "answer": "Unable to determine total assets as the balance sheet is not included in the provided context."
    },
    "75": {
        "reasoning": "1. To calculate fixed asset turnover ratio, I need:\n   - FY2018 Revenue\n   - FY2017 PP&E (Property and equipment, net)\n   - FY2018 PP&E (Property and equipment, net)\n\n2. From the context, I can identify:\n   - FY2018 Total Revenue: $83,989 million\n   - FY2017 PP&E: $10,292 million\n   - FY2018 PP&E: $11,349 million\n\n3. Calculate average PP&E:\n   - Average PP&E = ($10,292M + $11,349M) / 2\n   - Average PP&E = $10,820.5 million\n\n4. Calculate Fixed Asset Turnover Ratio:\n   - Ratio = $83,989M / $10,820.5M\n   - Ratio = 7.76",
        "answer": "7.76"
    },
    "76": {
        "reasoning": "1. To determine if CVS Health is capital-intensive, I'll analyze their capital expenditure patterns and nature from 2022:\n\n2. From the context, I found that in 2022:\n- Total capital expenditures were approximately $2.7 billion\n- The capital expenditures breakdown was:\n  * 73% for technology, digital and other strategic initiatives\n  * 27% for store, fulfillment and support facilities expansion and improvements\n\n3. Comparing this to other financial metrics:\n- Total revenues in 2022: $322,467 million\n- Capital expenditure as % of revenue = ($2.7B / $322.467B) \u2248 0.84%\n- This is a relatively low percentage of revenue spent on capital expenditures\n\n4. Additional contextual evidence:\n- The company's primary assets are service-based (pharmacy benefits management, insurance, retail locations)\n- Major investments are in technology and digital initiatives rather than heavy infrastructure\n- Operating model focuses on healthcare services, retail operations, and insurance rather than manufacturing or heavy infrastructure",
        "answer": "No, CVS Health is not a capital-intensive business based on FY2022 data. With capital expenditures representing less than 1% of revenue and a focus on service-based operations, the company's business model is more oriented toward operational efficiency and service delivery rather than heavy capital investments."
    },
    "77": {
        "reasoning": "1. Analyzing the context, several significant legal matters are identified from 2020-2022:\n\n2. Key Legal Issues:\n- Opioid Litigation: In December 2022, CVS agreed to a major settlement of approximately $4.3 billion plus $625 million in attorneys' fees to resolve opioid claims from states and political subdivisions\n- Additional opioid settlements include:\n  * Florida ($484 million over 18 years)\n  * Agreements with New Mexico, West Virginia, and Cherokee Nation\n  * Total pre-tax charges of $5.2 billion and $99 million recorded in Q3 and Q4 2022\n\n3. Other Notable Legal Matters:\n- PBM (Pharmacy Benefit Management) litigation regarding drug pricing and rebate arrangements\n- Multiple investigations by FTC and state Attorneys General\n- Medicare and Medicaid investigations regarding risk adjustment data submissions\n- Securities litigation related to LTC business unit performance\n- Usual and Customary Pricing litigation regarding retail pharmacy overcharging claims\n\n4. Financial Impact:\n- The opioid settlements represent the most materially significant legal impact\n- Company recorded over $5.3 billion in charges related to opioid settlements in 2022\n- Expected cash impact of less than $500 million each in 2023 and 2024\n\n5. Status:\n- Many cases are ongoing and being defended\n- Some settlements have been reached, particularly in opioid-related cases\n- Company acknowledges these legal matters could have material effect on business, financial condition, operating results and cash flows",
        "answer": "Yes, CVS Health has reported several materially important legal battles during 2020-2022, with the most significant being the nationwide opioid litigation resulting in settlements totaling over $5.3 billion in 2022. Other major ongoing legal matters include PBM pricing litigation, Medicare/Medicaid investigations, securities litigation, and retail pharmacy pricing disputes. The company acknowledges these legal matters could materially affect their business and financial condition."
    },
    "78": {
        "reasoning": "1. From the context, several key points about CVS Health's dividend history are noted:\n- The document states \"CVS Health Corporation has paid cash dividends every quarter since becoming a public company\"\n- During 2022, the quarterly cash dividend was $0.55 per share\n- This information is consistently mentioned multiple times throughout the document\n2. While the context doesn't explicitly state the Q2 2022 dividend payment, we can deduce that:\n- The company had an unbroken record of quarterly dividend payments\n- The standard quarterly dividend rate for all of 2022 was $0.55 per share\n- There are no mentions of any suspended or missed payments in 2022\n3. Therefore, based on the company's consistent dividend history and stated 2022 dividend rate, we can confidently conclude that CVS Health did pay a dividend in Q2 2022.",
        "answer": "Yes, CVS Health paid a quarterly cash dividend of $0.55 per share in Q2 2022."
    },
    "79": {
        "reasoning": "1 - According to the context, Mary N. Dillon, the new CEO of Foot Locker, was previously:\n- Executive Chair and CEO of Ulta Beauty, Inc. from July 2013 through June 2021\n- President and CEO of United States Cellular Corporation from 2010 through 2013\n\n2 - Analyzing the relevance to Foot Locker:\n- Ulta Beauty is particularly relevant as it is:\n  * A retail company focused on consumer products\n  * A successful omni-channel retailer\n  * Has a best-in-class loyalty program\n  * Under Dillon's leadership, achieved revenue CAGR of 16% and tripled market capitalization\n\n3 - While U.S. Cellular is less similar to Foot Locker's business model, Dillon's overall retail experience includes:\n- Over 35 years leading consumer-driven businesses\n- Deep consumer marketing and digital transformation expertise\n- Strong operational experience in retail\n- Experience in building robust brand portfolios",
        "answer": "Yes, Mary Dillon has directly relevant CEO experience, most notably as CEO of Ulta Beauty for eight years (2013-2021), where she successfully led a major retail company with similar characteristics to Foot Locker in terms of retail operations, omni-channel strategy, and customer loyalty focus."
    },
    "80": {
        "reasoning": "1. Based on the provided context, while there is mention of \"Proposal 1\" regarding the election of ten nominees to the Board of Directors, the actual voting results for individual nominees are not included in the given text.\n\n2. The context only states that there were \"votes cast for the proposal\" but does not provide the specific voting numbers or breakdown for any of the nominees.\n\n3. Without the actual voting data for each nominee, it's impossible to determine if any nominees received substantially more votes against them compared to others.",
        "answer": "Cannot be determined from the provided context as the specific voting results for board member nominees are not included in the text."
    },
    "81": {
        "reasoning": "1. Based on the provided context, I cannot calculate the Cash Conversion Cycle (CCC) because:\n   - The balance sheet data shown does not include inventory, accounts receivable, or accounts payable values\n   - While we have net sales (revenue) for FY2019 ($16,865.2M), we don't have COGS explicitly stated\n   - We don't have the necessary average balances between FY2018 and FY2019 for inventory, accounts receivable, and accounts payable\n\n2. The only financial data provided includes:\n   - Net sales\n   - Operating profit\n   - Total assets\n   - Long-term debt\n   - Total debt\n   - Cash flow information\n   But none of the specific line items needed for CCC calculation are present.\n\n3. Without the required balance sheet components (inventory, accounts receivable, accounts payable) and COGS figures, it's impossible to calculate DIO, DSO, and DPO, which are necessary for determining the CCC.",
        "answer": "Cannot be calculated due to missing required balance sheet data for inventory, accounts receivable, accounts payable, and income statement data for COGS."
    },
    "82": {
        "reasoning": "1 - From the provided context, I cannot directly calculate the working capital ratio because:\n  - The complete balance sheet information is not provided in the context\n  - Current assets and current liabilities are not fully listed in any of the given sections\n  - While there are mentions of some current items like \"Inventories\", \"Prepaid expenses\", \"Accounts payable\" and \"Other current liabilities\", we don't have the complete totals for either current assets or current liabilities\n\n2 - Without the complete balance sheet information showing total current assets and total current liabilities, it's impossible to accurately calculate the working capital ratio.\n\n3 - Since the specific information needed for this calculation is not available in the provided context, I cannot provide a meaningful answer.",
        "answer": "Cannot be calculated from the given information as complete current assets and current liabilities data is not provided in the context."
    },
    "83": {
        "reasoning": "1. Looking at the financial data, I need to find:\n   - Net cash provided by operating activities (cash from operations)\n   - Capital expenditures (capex)\n   For FY2020\n\n2. From the data provided:\n   - Net cash provided by operating activities for FY2020 = $3,676.2 million\n   - Capital expenditures for FY2020 = $460.8 million\n\n3. Calculate Free Cash Flow:\n   FCF = Cash from operations - Capex\n   FCF = $3,676.2 - $460.8 = $3,215.4 million\n\n4. Cross-check: This matches the directly reported \"Free cash flow\" line item shown in the financial data which shows $3,215.4 million for FY2020",
        "answer": "3,215.4"
    },
    "84": {
        "reasoning": "1. To calculate the retention ratio, we need the formula: Retention Ratio = (Net Income - Dividends) / Net Income\n\n2. From the Consolidated Statements of Earnings, I can find:\n   - Net earnings attributable to General Mills (2022): $2,707.3 million\n\n3. From the Consolidated Statements of Total Equity, I can find:\n   - Cash dividends declared ($2.04 per share for 2022)\n   - Looking at the detail, the total cash dividends were $1,244.5 million for 2022\n\n4. Calculating the retention ratio:\n   - Retention Ratio = ($2,707.3 - $1,244.5) / $2,707.3\n   - Retention Ratio = $1,462.8 / $2,707.3\n   - Retention Ratio = 0.5403 or 0.54 rounded to 2 decimal places",
        "answer": "0.54"
    },
    "85": {
        "reasoning": "1. From the provided context, I can analyze several key indicators to assess growth:\n\n2. Key findings from the context:\n   - The company is operating in three major segments: Consumer Health, Pharmaceutical, and MedTech\n   - They had to take significant charges in 2022:\n     * $1.5 billion in COVID-19 vaccine manufacturing exit costs\n     * $0.8 billion IPR&D impairment charge for bermekimab\n     * Faced commodity inflation challenges\n     * Experienced unfavorable changes in fair value of securities ($0.7 billion loss in 2022 vs. $0.5 billion gain in 2021)\n\n3. Performance indicators:\n   - Pharmaceutical segment's income before tax margin declined from 34.8% (2021) to 30.3% (2022)\n   - Consumer Health segment showed improvement from 10.5% (2021) to 19.6% (2022), but this was mainly due to lower litigation expenses\n   - Company is still investing significantly in R&D, though with lower milestone payments\n   - The company is conducting share repurchases ($2.5 billion worth)\n\n4. Based on these indicators, 2022 showed several challenges and one-time charges rather than strong organic growth signals. The margin compression in their key Pharmaceutical segment and various write-offs/exits suggest a transitional rather than high-growth period.",
        "answer": "No, J&J's FY2022 financials do not indicate a high-growth company, but rather show characteristics of a mature company managing through various operational challenges and transitions."
    },
    "86": {
        "reasoning": "1. Based on the provided context, there is no direct discussion of gross margin metrics or calculations.\n\n2. However, for a diversified healthcare company like Johnson & Johnson, analyzing gross margin alone may not be the most useful metric because:\n   - The company operates across three distinct segments (Consumer Health, Pharmaceutical, and MedTech)\n   - Each segment has different profitability profiles and operating dynamics\n   - The company focuses more on segment-level income before tax as a percentage of sales\n\n3. From the context, we can see that J&J provides more detailed segment-level profitability analysis:\n   - Consumer Health segment: Income before tax as % of sales improved from 10.5% (2021) to 19.6% (2022)\n   - Pharmaceutical segment: Income before tax as % of sales declined from 34.8% (2021) to 30.3% (2022)\n   - These metrics provide better insight into operational performance than gross margin would\n\n4. The context shows that profitability is significantly impacted by factors beyond gross margin, such as:\n   - Litigation expenses\n   - R&D investments\n   - One-time costs (like COVID-19 vaccine manufacturing exit costs)\n   - Brand marketing expenses\n   - Supply chain impacts",
        "answer": "Gross margin is not the most useful metric for analyzing Johnson & Johnson's performance. Instead, segment-level income before tax as a percentage of sales provides better insight, as it captures the distinct operational characteristics and profitability drivers of each business segment (Consumer Health, Pharmaceutical, and MedTech), along with significant impacts from litigation, R&D investments, and other segment-specific factors."
    },
    "87": {
        "reasoning": "1. Looking through the provided context, I do not see any information about:\n   - Cost of Goods Sold (COGS)\n   - Average or ending inventory values\n   - Any inventory-related metrics or data\n\n2. Without these fundamental data points, it's impossible to calculate the inventory turnover ratio, which is typically:\n   - Inventory Turnover = COGS / Average Inventory\n   or\n   - Inventory Turnover = Sales / Average Inventory\n\n3. The context primarily discusses:\n   - Segment performance\n   - Various litigation expenses\n   - Intangible assets\n   - Distribution channels\n   - But no inventory-specific information\n\n4. Therefore, I cannot provide the requested calculation based on the given context.",
        "answer": "Unable to calculate inventory turnover ratio as the provided context does not contain any inventory-related data or cost of goods sold information necessary for this calculation."
    },
    "88": {
        "reasoning": "1. From the context, I identify key EPS growth metrics:\n- 2022 full-year adjusted EPS growth was 3.6%\n- For 2023, company guides adjusted operational EPS of $10.50, reflecting growth of 3.5%\n\n2. Comparing the growth rates:\n- 2022 growth rate: 3.6%\n- 2023 projected growth rate: 3.5%\n\n3. Analysis:\n- The projected 2023 adjusted EPS growth rate (3.5%) is slightly lower than 2022's actual growth rate (3.6%)\n- This represents a marginal deceleration of 0.1 percentage points",
        "answer": "No, JnJ's adjusted EPS growth is not expected to accelerate in FY2023. The company projects 3.5% growth for 2023, which is slightly below the 3.6% growth achieved in 2022."
    },
    "89": {
        "reasoning": "1. From the context, I'll analyze the full-year 2022 sales data:\n\n2. For U.S. sales:\n- Full-year 2022 U.S. sales were $48,580 million\n- Full-year 2021 U.S. sales were $47,156 million\n- This represents a growth of 3.0% in the U.S.\n\n3. For International sales:\n- Full-year 2022 International sales were $46,363 million\n- Full-year 2021 International sales were $46,619 million\n- This represents a decline of -0.6% in total reported sales\n- Breaking this down further:\n  * Operational growth was +9.1%\n  * Currency impact was -9.7%\n\n4. Comparing the two:\n- U.S. showed steady positive growth at 3.0%\n- International showed a slight decline in reported sales (-0.6%) but had stronger operational growth (+9.1%) that was offset by significant negative currency impacts",
        "answer": "In FY2022, U.S. sales grew by 3.0% while International sales declined by 0.6% on a reported basis. However, International sales had stronger operational growth of 9.1% that was offset by a -9.7% currency impact."
    },
    "90": {
        "reasoning": "1. First, I analyzed the provided context from the 8-K filing dated August 30, 2023\n2. In the context, there is mention of \"separation of the Company's Consumer Health business\" in the forward-looking statements section\n3. There is also reference to \"the New Consumer Health Company's ability to succeed as a Standalone publicly traded company\"\n4. Based on these statements, it's clear that JnJ's Consumer Health segment is being separated from the main company\n5. While the context doesn't explicitly state it will be treated as discontinued operations, since it's being spun off as a standalone company, it would be treated as discontinued operations in financial reporting",
        "answer": "The Consumer Health business segment will be treated as a discontinued operation from August 30, 2023 onward."
    },
    "91": {
        "reasoning": "1. Looking through the provided context, I found relevant information in the GAAP to Non-GAAP Reconciliation table for the First Quarter ending April 2, 2023.\n\n2. In the \"Other (Income) / Expense\" row, there is a line item specifically related to \"Consumer Health separation\" with an amount of $(6,900) million.\n\n3. The negative amount in parentheses indicates this was a gain (reduction to expenses) rather than a loss.\n\n4. However, it's important to note that:\n   - This figure is from Q1 2023 (April 2, 2023), not specifically as of August 30, 2023\n   - This amount is in millions of dollars\n   - No updated figure for August 30, 2023 is provided in the context",
        "answer": "Based on the available context, a gain of $6.9 billion was recorded in Q1 2023 related to the Consumer Health separation, but the specific amount as of August 30, 2023 is not disclosed in the provided context."
    },
    "92": {
        "reasoning": "1. Analyzing the context from the press release dated August 30, 2023\n2. Located specific information about cash proceeds in the announcement: \"Company secured $13.2 billion in cash proceeds from the Kenvue debt offering and initial public offering\"\n3. The proceeds came from two sources:\n   - Kenvue debt offering\n   - Kenvue initial public offering (IPO)\n4. The amount is explicitly stated as a total figure combining both sources",
        "answer": "$13.2 billion"
    },
    "93": {
        "reasoning": "1. From the context, we need to analyze both sales and earnings figures to calculate net earnings as a percentage of sales\n2. Looking at the data provided, while we can see adjusted net earnings ($7,358M in 2023 vs $6,912M in 2022)\n3. However, we only have partial sales data (operational sales growth of 7.5% and adjusted operational sales growth of 6.2%)\n4. Without the absolute sales figures for either period, it's impossible to calculate net earnings as a percentage of sales for either year\n5. Therefore, we cannot definitively determine if net earnings as a percent of sales increased or decreased between Q2 2022 and Q2 2023",
        "answer": "Cannot be determined from the given context as complete sales figures are not provided."
    },
    "94": {
        "reasoning": "1. From the segment results in the context, I need to identify and compare net revenue figures for Q1 2021 across all business segments:\n\n2. Looking at the segment data for Q1 2021:\n- Consumer & Community Banking: $12,517 million\n- Corporate & Investment Bank: $14,605 million\n- Commercial Banking: $2,393 million\n- Asset & Wealth Management: $4,077 million\n- Corporate segment: $(473) million (negative revenue)\n\n3. Comparing these figures:\n$(473) million < $2,393 million < $4,077 million < $12,517 million < $14,605 million\n\n4. The Corporate segment had the lowest net revenue at $(473) million, which was actually negative, meaning it lost revenue during this period.",
        "answer": "The Corporate segment had the lowest net revenue at $(473) million in Q1 2021."
    },
    "95": {
        "reasoning": "1. To determine the per-share liquidation value, I need to analyze the total assets and book value metrics from the context:\n- Total assets as of 2021 Q1: $3,689,336 million\n- Book value per share: $82.31\n- Tangible book value per share: $66.56\n- Common shares at period-end: 3,027.1 million\n\n2. While total assets could theoretically be available for liquidation, this is not the most accurate measure since:\n- Assets would likely sell at a discount in a liquidation scenario\n- The company has liabilities that would need to be paid first\n- The tangible book value per share ($66.56) is a more conservative and realistic measure as it excludes goodwill and intangible assets\n\n3. Given these considerations, the tangible book value per share ($66.56) represents the most reasonable estimate of what shareholders might receive in a liquidation scenario after paying off all liabilities and selling all tangible assets.",
        "answer": "Each shareholder could theoretically receive approximately $66.56 per share based on the tangible book value per share as of 2021 Q1."
    },
    "96": {
        "reasoning": "1. First, I'll note that based on the provided context, there is no specific information about JPMorgan Chase's gross margins or their historical trends\n\n2. More importantly, gross margin is not actually a relevant metric for analyzing banking institutions like JPMorgan Chase for the following reasons:\n   - Banks don't have traditional \"cost of goods sold\" like manufacturing or retail companies\n   - Their primary business involves earning interest income, fees, and commissions\n   - Banks are typically evaluated using different metrics such as:\n     * Net interest margin (NIM)\n     * Efficiency ratio\n     * Return on equity (ROE)\n     * Return on assets (ROA)\n\n3. This is supported by the context which shows JPMorgan focuses on different types of metrics:\n   - The document discusses fair value measurements for assets and liabilities\n   - It mentions metrics related to Wealth Management and Payment services\n   - There is no mention of gross margins anywhere in the provided excerpts",
        "answer": "Gross margin is not a relevant metric for analyzing JPMorgan Chase or other banking institutions. Banks are financial intermediaries that primarily earn money through interest income, fees, and commissions, rather than selling physical products with associated cost of goods sold. More appropriate metrics for analyzing banks include net interest margin, efficiency ratio, return on equity, and return on assets."
    },
    "97": {
        "reasoning": "1. After reviewing the provided context, I cannot determine which business segment had the highest net income in Q2 2022\n2. While the context provides consolidated financial statements and highlights, it does not include segment-level breakdown of net income\n3. The context only shows the total net income of $8,649 million for Q2 2022 at the firm-wide level\n4. Without segment-specific information, it's impossible to compare the net income across different business segments",
        "answer": "Cannot be determined from the provided context as segment-level net income information is not available."
    },
    "98": {
        "reasoning": "1 - Looking at the VaR data table from the context, we need to compare Q2 2023 (Three months ended June 30, 2023) with Q2 2022 (Three months ended June 30, 2022)\n\n2 - For Q2 2023:\n- Total VaR average: $47 million\n- Total VaR range: Min $36 million, Max $56 million\n\n3 - For Q2 2022:\n- Total VaR average: $54 million\n- Total VaR range: Min $41 million, Max $71 million\n\n4 - Analyzing the data:\n- Average VaR decreased from $54M to $47M (13% decrease)\n- Maximum VaR decreased from $71M to $56M (21% decrease)\n- Minimum VaR decreased from $41M to $36M (12% decrease)\n\n5 - The decreases are seen across multiple risk types, particularly in CIB trading VaR which decreased from an average of $50M to $41M",
        "answer": "Yes, JPMorgan's risk exposure decreased in Q2 2023 compared to Q2 2022, as evidenced by lower VaR metrics across all measures - the average Total VaR declined from $54 million to $47 million, with both maximum and minimum values also showing significant decreases."
    },
    "99": {
        "reasoning": "1. Unfortunately, I cannot calculate the inventory turnover ratio accurately because:\n   - While I can see inventory values from the balance sheet (2019: $2,721M, 2018: $2,667M)\n   - The context provided does not include Cost of Goods Sold (COGS) information, which is a crucial component needed for this calculation\n   \n2. From the balance sheet data, I can calculate:\n   - Average inventory = ($2,721M + $2,667M) / 2 = $2,694M\n   \n3. However, without COGS data, I cannot complete the calculation:\n   - Inventory Turnover Ratio = COGS / Average Inventory\n   - COGS is not provided in any of the given context excerpts",
        "answer": "Cannot be calculated due to missing COGS (Cost of Goods Sold) data in the provided context."
    },
    "100": {
        "reasoning": "1. Unfortunately, from the provided context, I cannot calculate the asset turnover ratio because:\n   - While I can see the revenue (net sales) for FY2020 = $65,398 million\n   - The balance sheet information showing total assets for either FY2019 or FY2020 is not provided in the given context\n   - Without the total assets figures, it's impossible to calculate the average total assets between FY2019 and FY2020\n\n2. The formula would be:\n   Asset Turnover = $65,398 million / [(FY2019 total assets + FY2020 total assets) / 2]\n   But we're missing critical balance sheet data\n\n3. Therefore, I cannot provide even a reasonable approximation of the asset turnover ratio.",
        "answer": "Unable to calculate the asset turnover ratio due to missing balance sheet data on total assets for FY2019 and FY2020."
    },
    "101": {
        "reasoning": "1. From the balance sheet information provided, I can identify:\n- Total current assets for 2021: $19,815 million\n- Total current liabilities for 2021: $13,997 million\n\n2. To calculate net working capital:\n- Formula: Net Working Capital = Total Current Assets - Total Current Liabilities\n- Calculation: $19,815 million - $13,997 million = $5,818 million\n\n3. This positive net working capital indicates that Lockheed Martin has sufficient short-term assets to cover its short-term obligations, showing strong liquidity position.",
        "answer": "$5,818 million"
    },
    "102": {
        "reasoning": "1. I cannot determine the CAGR because I do not see the statement of income/earnings with revenue numbers in the provided context. While there are references to financial statements being included, the actual income statement data is not shown in the text excerpts provided.\n\n2. Without having the actual revenue numbers for FY2020 and FY2022, I cannot calculate:\n   - CAGR = (FY2022 Revenue/FY2020 Revenue)^(1/2) - 1\n\n3. The context contains accounting policies and notes but not the core financial statements needed to perform this calculation.",
        "answer": "Unable to calculate as the statement of income/earnings with revenue numbers is not provided in the context."
    },
    "103": {
        "reasoning": "1. Looking through the provided context, I need to find accounts payable in the balance sheet data\n2. Found accounts payable line item on page 172 of the 10-K\n3. As of December 31, 2018, accounts payable is listed as $25,758 thousand\n4. Converting thousands to millions: $25.758 million USD",
        "answer": "$25.76 million"
    },
    "104": {
        "reasoning": "1. From the provided context, I cannot directly find the capex (capital expenditure) numbers as the statement of cash flows is not provided in the context\n2. While we have revenue numbers from the income statement:\n   - 2020: $5,162,082,000\n   - 2019: $12,899,672,000\n   - 2018: $11,763,096,000\n3. Without the statement of cash flows showing capital expenditures, it's impossible to accurately calculate capex as a percentage of revenue\n\n4. Since a core required data point (capex) is missing from the provided context, I cannot calculate this metric accurately",
        "answer": "Unable to calculate due to missing capital expenditure data in the provided context."
    },
    "105": {
        "reasoning": "1. Looking through the context, I found information about MGM Resorts' dividend payments in 2022:\n2. According to the text, in 2022, MGM paid quarterly dividends of $0.0025 per share in March, June, September, and December\n3. The total dividend payments for 2022 amounted to $4 million\n4. Additionally, it's worth noting that on February 8, 2023, MGM announced the suspension of ongoing dividends to focus on share repurchases as their preferred method of returning value to shareholders",
        "answer": "Yes, MGM Resorts paid quarterly dividends of $0.0025 per share in 2022, totaling $4 million for the year."
    },
    "106": {
        "reasoning": "1. Looking at the financial data for FY2022 across regions:\n- Las Vegas Strip Resorts: $3.1 billion EBITDAR\n- Regional Operations: $1.3 billion EBITDAR\n- MGM China: -$203 million EBITDAR (loss)\n\n2. Analyzing the relative performance:\n- Las Vegas Strip Resorts had the highest EBITDAR at $3.1 billion\n- Regional Operations was second with $1.3 billion\n- MGM China had negative EBITDAR, indicating losses\n\n3. The Las Vegas Strip Resorts segment also showed:\n- Strong margin performance at 37.4%\n- 81% increase in EBITDAR from prior year\n- Benefited from acquisitions like The Cosmopolitan",
        "answer": "Las Vegas Strip Resorts had the highest EBITDAR contribution in FY2022 with $3.1 billion."
    },
    "107": {
        "reasoning": "1. To calculate interest coverage ratio, I need to find:\n   - FY2022 Adjusted EBIT (Operating Income before Interest and Taxes)\n   - FY2022 Interest Expense\n\n2. From the financial data:\n   - FY2022 Operating Income = $1,439,372,000\n   - FY2022 Interest Expense = $594,954,000\n\n3. For a more accurate EBIT calculation, we should add back one-time items:\n   - Add back: Preopening expenses of $1,876,000\n   - Add back: Property transactions, net of ($1,036,997,000)\n   \n4. Adjusted EBIT = $1,439,372,000 + $1,876,000 - $1,036,997,000 = $404,251,000\n\n5. Interest Coverage Ratio = Adjusted EBIT / Interest Expense\n   = $404,251,000 / $594,954,000 = 0.68x",
        "answer": "0.68x"
    },
    "108": {
        "reasoning": "1. From the financial data provided in the context, I can analyze the performance across different regions:\n2. Looking at the financial table, we can see performance for:\n   - Las Vegas Strip Resorts: $3,142,308,000 in 2022\n   - Regional Operations: $1,294,630,000 in 2022\n   - MGM China: ($203,136,000) in 2022\n3. Among these regions, MGM China is the only one showing negative numbers for 2022\n4. This is further supported by the detailed gaming statistics for MGM China showing significant declines:\n   - VIP table games turnover down 44%\n   - VIP table games win down 62%\n   - Main floor table games drop down 45%\n5. The negative performance in China represents the worst topline performance among all regions",
        "answer": "MGM China had the worst topline performance during FY2022, showing a negative result of ($203,136,000) while other regions remained positive."
    },
    "109": {
        "reasoning": "1. Looking at the short-term investments table in the provided context, specifically on page 9\n2. The table shows different types of debt investments including:\n   - U.S. government securities: $57,696\n   - U.S. agency securities: $29,049\n   - Commercial paper and certificates of deposit: $4,561\n   - Corporate bonds: $416,420\n\n3. Comparing the values:\n   - Corporate bonds at $416,420 thousand is significantly larger than all other categories\n   - This represents more than 80% of total short-term investments",
        "answer": "Corporate bonds were the largest short-term debt investment with $416,420 thousand."
    },
    "110": {
        "reasoning": "1. After reviewing the provided context, I cannot directly find Cost of Goods Sold (COGS) for FY2016 in the given text excerpts\n2. The context provided appears to include:\n   - Some revenue breakdowns by product\n   - Notes about income before taxes\n   - Independent auditor's report\n   - Management discussion\n   - Some other financial metrics\n3. Without access to the complete income statement, I cannot definitively state Microsoft's COGS for FY2016\n4. While there are various financial figures mentioned (like revenue numbers for different products), none specifically indicate the COGS figure",
        "answer": "Cannot determine from the given context. The COGS figure is not provided in the available financial statement excerpts."
    },
    "111": {
        "reasoning": "1. Looking through the provided context, there is no explicit comparison of debt balances between FY2023 and FY2022.\n\n2. While there are references to debt in the context:\n   - There's mention of debt proceeds being used for general corporate purposes\n   - There's a reference to \"Note 11 \u2014 Debt\" in the financial statements\n   - There's mention of a \"$6.3 billion decrease in repayments of debt\" in the cash flow discussion\n\n3. However, without seeing the actual balance sheet numbers or specific debt disclosures, I cannot definitively determine if the total debt on the balance sheet increased or decreased between these periods.\n\n4. The only debt-related quantitative information we have is about debt repayments being $6.3 billion lower than the previous year, but this alone doesn't tell us about the net change in debt balance as new debt could have been issued.",
        "answer": "Based on the provided context, there is insufficient information to determine whether Microsoft's debt on balance sheet increased or decreased between FY2023 and FY2022."
    },
    "112": {
        "reasoning": "1. After reviewing the provided context, I cannot calculate Netflix's FY2015 unadjusted EBITDA % margin because:\n\n2. The context does not contain:\n   - Complete income statement showing operating income\n   - Complete cash flow statement showing depreciation and amortization\n   - Revenue figures (only mentions a 23% increase in revenues but not absolute numbers)\n\n3. While there are mentions of financial metrics like:\n   - Operating income decreased in 2015 vs 2014 (but no specific numbers)\n   - Revenue increased by 23% in 2015\n   - Free cash flow was mentioned\nNone of these provide the specific numbers needed to calculate EBITDA margin.\n\n4. The EBITDA % margin calculation would require:\n   - Operating Income\n   - Depreciation & Amortization\n   - Revenue\nTo calculate: (Operating Income + D&A) / Revenue * 100",
        "answer": "Cannot calculate FY2015 unadjusted EBITDA % margin due to insufficient financial data in the provided context. The required operating income, depreciation & amortization, and revenue figures are not available in the given excerpts."
    },
    "113": {
        "reasoning": "1. Looking at the consolidated balance sheet for Netflix as of December 31, 2017\n2. Under current liabilities section, I can identify the following components:\n   - Current content liabilities: $4,173,041 thousand\n   - Accounts payable: $359,555 thousand\n   - Accrued expenses: $315,094 thousand\n   - Deferred revenue: $618,622 thousand\n3. Adding these components together:\n   4,173,041 + 359,555 + 315,094 + 618,622 = 5,466,312 thousand\n4. The balance sheet directly shows total current liabilities as $5,466,312 thousand\n5. Converting to millions by dividing by 1000: 5,466,312/1000 = 5,466.31 million",
        "answer": "$5,466.31 million"
    },
    "114": {
        "reasoning": "1. Unfortunately, the provided context does not contain direct cost of goods sold (COGS) information. The context only shows:\n- Revenue breakdowns by product category (Footwear, Apparel, Equipment)\n- Revenue breakdowns by channel (Wholesale, NIKE Direct)\n- Total revenues for FY2016-2018 ($32,376M, $34,350M, and $36,397M respectively)\n- Some regional breakdowns and EBIT figures\n\n2. Without explicit COGS data, we cannot calculate the exact gross margin or COGS as a percentage of revenue.\n\n3. This is a key limitation of the provided context, and we cannot make a reasonable approximation without making potentially inaccurate assumptions about NIKE's cost structure.",
        "answer": "Cannot be calculated from the provided context as cost of goods sold information is not available in the given financial data."
    },
    "115": {
        "reasoning": "1. Looking through the provided context, I notice that there is no complete balance sheet presented that would show total current assets directly.\n\n2. However, I can see some components that would typically be part of current assets:\n   - Accounts Receivable, Net for 2019: $4,272 million\n   - Inventories for 2019: $5,622 million\n\n3. This is incomplete information as other important current asset components like:\n   - Cash and cash equivalents\n   - Short-term investments\n   - Prepaid expenses\n   are not provided in the context\n\n4. Therefore, I cannot calculate the total current assets accurately from the given information.",
        "answer": "Cannot be determined from the given context. While some current assets are shown (Accounts Receivable of $4,272M and Inventories of $5,622M), other crucial components of current assets are not provided in the context."
    },
    "116": {
        "reasoning": "1. Based on the provided context, I cannot directly calculate the inventory turnover ratio because:\n   - The context does not provide Cost of Goods Sold (COGS) information for FY2021\n   - The context does not provide inventory balances for either FY2020 or FY2021\n\n2. While we can see revenue figures, operating metrics, and some segment information, the key components needed for the inventory turnover calculation (COGS and inventory balances) are not present in the given excerpts.\n\n3. Without these essential data points, it's impossible to calculate the inventory turnover ratio accurately.",
        "answer": "Cannot be calculated from the provided context as COGS and inventory balance information is not available."
    },
    "117": {
        "reasoning": "1 - From the context, let's identify the cash flows for each activity in FY2023:\n   - Operating activities: Cash inflow of $5,841 million\n   - Investing activities: Cash inflow of $564 million \n   - Financing activities: Cash outflow of $7,447 million\n\n2 - Comparing the three:\n   - Operations: +$5,841 million\n   - Investing: +$564 million\n   - Financing: -$7,447 million\n\n3 - Operating activities had the highest positive cash flow at $5,841 million, making it the category that brought in the most cash for Nike in FY2023.",
        "answer": "Operating activities brought in the most cash flow with an inflow of $5,841 million in FY2023."
    },
    "118": {
        "reasoning": "1. From the provided context, I cannot directly calculate working capital (current assets minus current liabilities) as the specific balance sheet figures are not provided in the given excerpts.\n\n2. However, I can provide important context about PayPal's business model that makes traditional working capital analysis less relevant:\n\n3. Key business model insights from the context:\n- PayPal operates a two-sided payment network connecting 435M active accounts\n- They primarily earn revenue through transaction fees\n- They hold customer funds and facilitate money movement\n- They have significant funds receivable and customer accounts\n- As a financial technology company, their balance sheet includes large amounts of customer funds that are pass-through in nature\n\n4. Working capital is less meaningful for PayPal because:\n- As a payment platform, they maintain large amounts of customer funds that appear on their balance sheet but aren't truly operating assets\n- Their business is not inventory or working capital intensive like traditional businesses\n- Their primary assets are technology infrastructure and customer relationships rather than working capital components",
        "answer": "Working capital is not a particularly useful metric for analyzing PayPal. As a payment platform company, their balance sheet structure is fundamentally different from traditional businesses, with large amounts of customer funds and receivables that are pass-through in nature rather than true operating working capital. Their business model is based on facilitating payments and earning transaction fees, not managing traditional working capital cycles."
    },
    "119": {
        "reasoning": "1. Unfortunately, the provided context does not contain the detailed statement of cash flows information that would show capital expenditures\n2. While references to the cash flow statement are mentioned (pages 60-61), the actual capital expenditure figures are not visible in the provided excerpts\n3. As a financial analyst, I cannot make assumptions about capital expenditure amounts without seeing the investing activities section of the cash flow statement\n4. While other financial information like balance sheet items are shown, capital expenditures are specifically a cash flow statement item that cannot be directly derived from the given information",
        "answer": "Based on the limited context provided from the cash flow statement, I cannot determine PepsiCo's FY2021 capital expenditure amount."
    },
    "120": {
        "reasoning": "1. From the context, I can identify PepsiCo's global operational presence details:\n2. The document specifically states that PepsiCo operates \"in more than 200 countries and territories\"\n3. The largest operations are explicitly mentioned to be in:\n   - United States\n   - Mexico\n   - Russia\n   - Canada\n   - China\n   - United Kingdom\n   - South Africa\n4. PepsiCo is organized into seven reportable segments covering distinct geographical regions:\n   - Frito-Lay North America (US and Canada)\n   - Quaker Foods North America (US and Canada)\n   - PepsiCo Beverages North America (US and Canada)\n   - Latin America\n   - Europe\n   - Africa, Middle East and South Asia (AMESA)\n   - Asia Pacific, Australia and New Zealand and China region (APAC)",
        "answer": "While PepsiCo operates in over 200 countries and territories, its largest operations are concentrated in the United States, Mexico, Russia, Canada, China, the United Kingdom, and South Africa. The company organizes its business across seven major geographical segments covering North America, Latin America, Europe, Africa, Middle East, South Asia, Asia Pacific, Australia, New Zealand, and China region."
    },
    "121": {
        "reasoning": "1. Analyzing the context from PEPSICO_2022_10K.pdf_page_23, which discusses legal matters:\n- The company acknowledges being party to various litigation, claims, and legal proceedings\n- These include matters related to:\n  * Advertising and marketing practices\n  * Product labels and ingredients\n  * Personal injury and property damage\n  * Intellectual property rights\n  * Privacy\n  * Employment\n  * Tax and insurance\n  * Environmental, social and governance matters\n\n2. Looking at the materiality disclosure:\n- The document notes these matters are \"inherently uncertain\"\n- There's no guarantee of successful defense\n- Their assessment of materiality and potential losses may not match ultimate outcomes\n\n3. Checking specific disclosures:\n- From page 23, there is no mention of any specific, material ongoing legal battle\n- Under \"Unresolved Staff Comments\" section, there are no unresolved SEC comments\n- No specific material litigation is highlighted in the financial statements or other provided context",
        "answer": "While PepsiCo acknowledges being party to various legal proceedings and claims, they have not reported any specific materially important ongoing legal battles in their 2022 10-K disclosure from the provided context. The company discloses general legal risks but does not highlight any specific material litigation requiring individual disclosure."
    },
    "122": {
        "reasoning": "1. Looking through the provided context, I found detailed restructuring information on page 76 of the 10-K\n2. For FY2022, the breakdown of restructuring and impairment charges shows:\n   - Cost of sales: $33 million\n   - Selling, general and administrative expenses: $347 million\n   - Other pension and retiree medical benefits expense: $31 million\n3. The total restructuring and impairment charges for 2022 is clearly stated as $411 million\n4. This matches with other references in the financial statements, such as page 46 which shows restructuring and impairment charges as a reconciling item",
        "answer": "$411 million"
    },
    "123": {
        "reasoning": "1. From the provided context, I can see that the unadjusted (GAAP) operating profit for FY2022 is $11,512 million (from the income statement data)\n\n2. However, I am unable to calculate EBITDA precisely because:\n   - The depreciation and amortization figures from the cash flow statement are not provided in the given context\n   - The cash flow statement details, while mentioned in the document structure, are not actually shown in the provided text extracts\n\n3. Additionally, I cannot determine capex (capital expenditures) because:\n   - This would typically be found in the cash flow statement under investing activities\n   - The detailed cash flow statement is not included in the provided context\n\n4. Therefore, while I can see the operating profit of $11,512M, I cannot calculate the complete EBITDA less capex figure without the missing cash flow statement components",
        "answer": "Unable to calculate due to missing depreciation, amortization, and capital expenditure data from the cash flow statement. The only known component is operating profit of $11,512M for FY2022."
    },
    "124": {
        "reasoning": "1 - To calculate unadjusted EBITDA % margin, I will use the formula:\n(Operating Income + Depreciation & Amortization) / Net Revenue x 100\n\n2 - From the provided P&L statement (page 60):\n- Net Revenue for FY2022: $86,392 million\n- Operating Income for FY2022: $11,512 million\n\n3 - Unfortunately, I cannot find the Depreciation & Amortization figures in the provided context as the complete cash flow statement details are not visible in the given excerpts.\n\n4 - Without the D&A figures from the cash flow statement, I cannot calculate the complete unadjusted EBITDA margin. The calculation would be incomplete and potentially misleading.",
        "answer": "Unable to calculate the FY2022 unadjusted EBITDA % margin as Depreciation & Amortization figures are not available in the provided context."
    },
    "125": {
        "reasoning": "1. From the context, I can identify this was discussed at PepsiCo's 2023 Annual Meeting of Shareholders on May 3, 2023\n2. Looking at the voting results in the document, specifically related to the shareholder proposal regarding a congruency report on net-zero emissions policies\n3. The document explicitly states this proposal \"was defeated\"\n4. The voting results show numbers: \"Against Abstain 23200321\", indicating opposition to the proposal\n5. This clearly indicates that shareholders voted against this proposal, resulting in its defeat",
        "answer": "The shareholder proposal for a congruency report on net-zero emissions policies was defeated at the PepsiCo AGM."
    },
    "126": {
        "reasoning": "1. From the context, I can see that PepsiCo terminated their existing 2022 Five Year Credit Agreement which was for $3,800,000,000\n2. On May 26, 2023, they entered into a new Five Year Credit Agreement for $4,200,000,000\n3. To calculate the increase:\n   $4,200,000,000 - $3,800,000,000 = $400,000,000\n\n4. The increase shows that PepsiCo expanded their revolving credit facility capacity with this new agreement.",
        "answer": "PepsiCo increased its unsecured five year revolving credit agreement by $400,000,000 on May 26, 2023."
    },
    "127": {
        "reasoning": "1. Identify the two credit agreements mentioned in the context:\n   - 2023 364 Day Credit Agreement: $4,200,000,000\n   - 2023 Five Year Credit Agreement: $4,200,000,000\n\n2. Consider potential increases under both agreements:\n   - Both agreements allow increase up to $4,950,000,000 each (with agreement of existing lenders or additional banks)\n\n3. Calculate base total borrowing capacity:\n   - Base amount = $4,200,000,000 + $4,200,000,000 = $8,400,000,000\n\n4. Note maximum potential with increases:\n   - Maximum potential = $4,950,000,000 + $4,950,000,000 = $9,900,000,000\n   \n5. Since the question asks for current amount (as of May 26, 2023), we should use the base amount before any potential increases.",
        "answer": "$8,400,000,000"
    },
    "128": {
        "reasoning": "1. From reviewing the provided context, while there is a mention in the title that \"PepsiCo Reports First-Quarter 2023 Results; Raises Full-Year Guidance\", there are no specific details provided about the reasons for raising guidance.\n\n2. The context mainly contains:\n   - Definitions of non-GAAP measures\n   - Information about how guidance is calculated\n   - Various risk factors and forward-looking statements\n   - Details about acquisitions and divestitures\n\n3. Without specific information about Q1 2023 financial performance or management's commentary on guidance revision, I cannot definitively state the exact reason for raising full-year guidance.\n\n4. The only guidance-related information provided is technical details about how 2023 guidance is calculated, specifically regarding organic revenue growth, core effective tax rate, and core constant currency EPS growth.",
        "answer": "Based on the provided context, while it is confirmed that PepsiCo raised its full-year guidance for FY2023, the specific reasons for this guidance raise are not detailed in the given text excerpts."
    },
    "129": {
        "reasoning": "1. From the context, I found the relevant quote from CEO Ramon Laguarta: \"Given our strong start to the year, we now expect our full-year 2023 organic revenue to increase 8 percent (previously 6 percent) and core constant currency EPS to increase 9 percent (previously 8 percent)\"\n\n2. For core constant currency EPS growth:\n   - New guidance: 9 percent\n   - Previous guidance: 8 percent\n   \n3. Calculate the change:\n   - 9% - 8% = 1 percentage point increase",
        "answer": "1 percentage point"
    },
    "130": {
        "reasoning": "1. Checking the provided context for Property, Plant and Equipment (PPNE) values:\n2. From the balance sheet, I can find the PPNE value:\n   - 2021 PPNE: $14,882 million\n   - 2020 PPNE value is not directly visible in the provided context\n\n3. Without having both years' PPNE values, I cannot definitively determine if there was growth between FY20 and FY21.",
        "answer": "Unable to determine based on the provided context, as the 2020 PPNE value is not shown in the financial statements."
    },
    "131": {
        "reasoning": "1. From the context, I specifically looked for unusual or significant items that impacted Pfizer's 2019 financial performance.\n\n2. In the financial data, there is a significant item listed for 2019: \"(Gain) on completion of Consumer Healthcare JV transaction\" of $8,107 million.\n\n3. This is explicitly called out as a non-standard business operation because:\n   - It appears in the \"Certain Significant Items\" section which the context defines as \"items that are not part of our ongoing business\"\n   - It's a one-time transaction related to completing a joint venture\n   - The magnitude ($8.1 billion) is substantial relative to the overall net income\n\n4. This gain significantly impacted the net income in 2019, as evident from the financials where it contributed $8,107 million to income.",
        "answer": "Yes, the completion of the Consumer Healthcare JV transaction resulted in a substantial one-time gain of $8,107 million in 2019, which significantly increased Pfizer's net income for that year."
    },
    "132": {
        "reasoning": "1. Analyzing the company names in the context, I can identify subsidiaries that were likely acquired based on their distinct brand names and corporate structures:\n\n2. Key acquisitions identified from the subsidiary list:\n- King Pharmaceuticals (evidenced by multiple King-named entities: King Pharmaceuticals Holdings LLC, King Pharmaceuticals LLC, King Pharmaceuticals Research and Development, LLC)\n- Medivation (evidenced by multiple Medivation entities: Medivation LLC, Medivation Field Solutions LLC, Medivation Neurology LLC, Medivation Prostate Therapeutics LLC)\n- Wyeth (evidenced by multiple Wyeth-named entities: Laboratorios Wyeth LLC, John Wyeth & Brother Limited, Wyeth-related subsidiaries)\n\n3. These represent significant acquisitions based on:\n- The presence of multiple subsidiary entities under each brand\n- Their establishment as distinct LLC structures\n- Their geographic spread across multiple countries",
        "answer": "Three main companies acquired by Pfizer are King Pharmaceuticals, Medivation, and Wyeth."
    },
    "133": {
        "reasoning": "1. From the context, Pfizer expects to incur costs of approximately $700 million in connection with separating Upjohn\n2. As of Q2 2023, approximately 90% of these costs have already been incurred since inception\n3. Therefore, the remaining costs to be incurred would be approximately 10% of $700 million\n4. Calculation: $700 million \u00d7 0.10 = $70 million remaining to be paid",
        "answer": "$70 million"
    },
    "134": {
        "reasoning": "1. From the context, I'll analyze the geographic revenue decline information:\n2. From page 43, there's a breakdown of revenue changes by geographic regions (US vs International)\n3. For US:\n   - Total decline: $5,037 million\n   - From a base of higher revenues in Q2 2022\n4. For International:\n   - Total decline: $9,971 million (including $283M forex impact)\n   - This represents a larger absolute decline than US\n5. Looking at total company revenues in Q2 (page 39):\n   - Q2 2023: $12.7 billion\n   - Q2 2022: $27.7 billion\n   - Total decline: $15.0 billion or 54%\n6. The international segment had both a larger absolute decline ($9.971B vs $5.037B) and appears to represent a larger percentage drop relative to its base, given that international markets historically represent a smaller portion of total revenues",
        "answer": "International markets saw the bigger percentage drop in Q2 2023 year-over-year revenues."
    },
    "135": {
        "reasoning": "1. First, I'll examine the context for any mention of spin-offs or business separations:\n- There is mention of the historical Upjohn Business spin-off that was completed in November 2020, where it was combined with Mylan to create Viatris\n- Looking at current/ongoing spin-offs, the context shows:\n  * There is a July 2023 agreement to divest early-stage rare disease gene therapy portfolio to Alexion\n  * The company is reorganizing its R&D operations, particularly in oncology, but this is an internal reorganization rather than a spin-off\n2. Analyzing the scale of these changes:\n  * The rare disease gene therapy portfolio sale is worth up to $1 billion, which is relatively small compared to Pfizer's overall size\n  * The R&D reorganization is internal and not a spin-off\n3. Evaluating timing:\n  * The only significant spin-off mentioned (Upjohn) is historical from 2020\n  * Current changes are either small divestitures or internal reorganizations",
        "answer": "No, as of Q2'2023, Pfizer is not spinning off any large business segments. While they are divesting their early-stage rare disease gene therapy portfolio to Alexion, this is a relatively small transaction and not a major business segment spin-off."
    },
    "136": {
        "reasoning": "1. Analyzing the context for information about registered securities:\n2. Found in the first section that only Ulta Beauty's common stock is listed for trading, specifically \"Common stock, par value $0.01 per share ULTA The NASDAQ Global Select Market\"\n3. Reviewed all provided context sections, including market information and trading details\n4. Found no mention of any debt securities registered for trading on any national securities exchange\n5. Confirmed that the only security explicitly mentioned as being registered and traded is the common stock on NASDAQ Global Select Market",
        "answer": "Based on the provided context, Ulta Beauty has no debt securities registered to trade on any national securities exchange. Only its common stock is registered to trade on the NASDAQ Global Select Market."
    },
    "137": {
        "reasoning": "1. Analyzing the provided context for information about acquisitions:\n2. Reviewing the \"Business and basis of presentation\" section shows no mention of acquisitions\n3. Looking through financial notes and other sections, there is no mention of any major acquisitions\n4. The only significant business expansion mentioned is the partnership with Target Corporation to create \"Ulta Beauty at Target\" shop-in-shop concept, but this is not an acquisition\n5. Without any explicit mention of acquisitions in the given context, and considering this is from their 10-K filing which would typically disclose such information, it appears there were no major acquisitions during these periods",
        "answer": "Based on the provided context, there is no evidence of any major acquisitions by Ulta Beauty in FY2023 or FY2022. The company's main expansion activity was through organic growth and the Target partnership."
    },
    "138": {
        "reasoning": "1. Extract key SG&A metrics from context:\n- SG&A expenses increased 16.2% to $2.4 billion compared to $2.1 billion in fiscal 2021\n- As a percentage of net sales, SG&A decreased to 23.5% compared to 23.9% in fiscal 2021\n\n2. Identify the specific factors mentioned that drove the reduction:\n- Lower marketing expenses\n- Leverage of incentive compensation due to higher sales\n\n3. Note offsetting factors that partially counteracted the reduction:\n- Deleverage of corporate overhead due to strategic investments\n- Deleverage of store payroll and benefits due to wage investments\n\n4. Analyze the net sales growth impact:\n- Net sales increased 18.3% to $10.2 billion from $8.6 billion\n- The strong sales growth helped achieve better expense leverage despite absolute dollar increase in SG&A",
        "answer": "The reduction in SG&A as a percent of net sales was primarily driven by lower marketing expenses and leverage of incentive compensation due to higher sales, although this was partially offset by deleverage from corporate overhead investments and increased store payroll costs."
    },
    "139": {
        "reasoning": "1. Located inventory information in the context which shows merchandise inventories increased from $1.5 billion in Q4 FY2021 to $1.6 billion in Q4 FY2022\n2. Identified the specific dollar increase: $104.2 million\n3. Extracted three main drivers of the inventory increase:\n   - Opening of 47 new stores since January 29, 2022\n   - Inventory needed to support new brand launches and brand expansions\n   - Inventory cost increases",
        "answer": "The $104.2 million increase in merchandise inventories was primarily driven by three factors: the opening of 47 new stores, inventory to support new brand launches and brand expansions, and inventory cost increases."
    },
    "140": {
        "reasoning": "1. From the context, I identified:\n- Q4 FY2022 stock repurchases: $328.1 million (722,457 shares)\n- Full year FY2022 stock repurchases: $900.0 million (2.2 million shares)\n\n2. To calculate the percentage:\n- ($328.1 million \u00f7 $900.0 million) \u00d7 100 = 36.46%\n\n3. This indicates that about 36.46% of Ulta Beauty's total stock repurchases for fiscal year 2022 occurred in Q4",
        "answer": "36.46%"
    },
    "141": {
        "reasoning": "1 - From the context, I'll analyze SG&A (Selling, General and Administrative) expenses details specifically related to wages\n2 - In the fiscal 2022 summary, there's a specific mention that there was \"deleverage of store payroll and benefits due to wage investments\"\n3 - The text states that while overall SG&A as a percentage of sales decreased from 23.9% to 23.5%, this improvement was \"partially offset by deleverage of corporate overhead due to strategic investments and deleverage of store payroll and benefits due to wage investments\"\n4 - \"Deleverage\" in this context means the expense grew at a faster rate than sales, indicating that wages as a percentage of sales increased\n5 - The wage investments specifically contributed to this deleverage, confirming an increase in wages as a percentage of sales",
        "answer": "Wages expense as a percent of net sales increased in FY2023, as indicated by the deleverage in store payroll and benefits due to wage investments."
    },
    "142": {
        "reasoning": "1. Let's identify all derivative instruments and their notional values for 2021 from the context:\n- Interest Rate Swaps: $19.8 billion\n- Forward Starting Interest Rate Swaps: $1.0 billion\n- Treasury Rate Locks: $0 (no outstanding notional amount)\n- Cross Currency Swaps: $32.5 billion\n- Foreign Exchange Forwards: $932 million (plus additional $12.604 billion entered into during 2021)\n- Swaptions: $2.0 billion\n\n2. Comparing the notional values:\n- $32.5 billion (Cross Currency Swaps)\n- $19.8 billion (Interest Rate Swaps)\n- $12.604 billion (Foreign Exchange Forwards entered)\n- $2.0 billion (Swaptions)\n- $1.0 billion (Forward Starting Interest Rate Swaps)\n- $0 (Treasury Rate Locks)\n\n3. The Cross Currency Swaps clearly had the highest notional value at $32.5 billion in 2021.",
        "answer": "Cross Currency Swaps with a notional value of $32.5 billion was the derivative instrument with the highest notional value in 2021."
    },
    "143": {
        "reasoning": "1. From the context, I located the payment schedule table on page 92 that breaks down expected payments for both Pension Benefits and Health Care and Life benefits by year\n2. For the year 2024, the table shows:\n   - Pension Benefits: $1,097 million\n   - Health Care and Life: $862 million\n3. To get the total expected payments for 2024, I added both amounts:\n   $1,097 million + $862 million = $1,959 million",
        "answer": "$1,959 million"
    },
    "144": {
        "reasoning": "1. Looking at the provided context, I cannot find complete information about current assets (cash, marketable securities, accounts receivable) and current liabilities that would be needed to calculate the quick ratio\n2. While I can see that Verizon had $2.6 billion in cash and cash equivalents plus $1.5 billion in restricted cash as of December 31, 2022, other components like accounts receivable and current liabilities are not provided\n3. Without the complete balance sheet information, it would not be accurate to calculate or assess Verizon's quick ratio\n4. However, the context does provide some indirect indicators of liquidity:\n   - Verizon maintained stable credit ratings in 2022 and 2021\n   - The company is in compliance with all restrictive covenants in its debt agreements\n   - They have sufficient cash management practices including segregated accounts for certain receivables",
        "answer": "Based on the limited context provided, I cannot assess Verizon's liquidity profile using the quick ratio as the necessary balance sheet components (accounts receivable and current liabilities) are not available in the given information. However, stable credit ratings and compliance with debt covenants suggest some degree of financial stability."
    },
    "145": {
        "reasoning": "1. Looking at key capital expenditure metrics from 2022:\n   - Capital expenditures were $23.1 billion in 2022, up from $20.3 billion in 2021\n   - This represents about 16.9% of 2022 operating revenues ($136.8 billion)\n\n2. Analyzing the nature of capital investments:\n   - Company states 2022 was a \"peak year of capital investment\"\n   - Major capital requirements include:\n     * Wireless spectrum acquisition\n     * Network capacity expansion\n     * Fiber infrastructure investment\n     * Advanced IT systems development\n     * 5G technology deployment\n\n3. Strategic importance of capital investments:\n   - Essential for maintaining network leadership\n   - Required for deploying C-Band spectrum\n   - Necessary for evolving to 5G wireless networks\n   - Critical for developing \"Intelligent Edge Network\"\n\n4. Management explicitly acknowledges their \"strategy requires significant capital investments\" to maintain competitive position and drive growth",
        "answer": "Yes, Verizon is definitely a capital intensive business, as evidenced by its substantial $23.1 billion capital expenditure in 2022 (16.9% of revenue) and ongoing requirements for significant network, spectrum, and infrastructure investments."
    },
    "146": {
        "reasoning": "1. Looking at the total debt figures from the provided context:\n- 2022 total debt: $150,639 million\n- 2021 total debt: $150,868 million\n\n2. Breaking down the debt components:\n- Long-term debt (2022): $140,676 million vs 2021: $143,425 million\n- Debt maturing within one year (2022): $9,963 million vs 2021: $7,443 million\n- Commercial paper added in 2022: $150 million (not present in 2021)\n\n3. Calculating the net change:\n- $150,639 - $150,868 = -$229 million decrease from 2021 to 2022\n\n4. Additional context shows that while total debt slightly decreased, there were changes in the debt composition:\n- Shift from longer-term to shorter-term debt\n- Changes in interest rates and floating rate debt\n- Some debt restructuring across different maturity periods",
        "answer": "No, Verizon's total debt slightly decreased by $229 million, from $150,868 million in 2021 to $150,639 million in 2022."
    },
    "147": {
        "reasoning": "1. Unfortunately, from the provided context, I cannot calculate the DPO because:\n   - While we have inventory values for FY2017 ($43,046M) and FY2018 ($43,783M)\n   - We don't have accounts payable values for either year\n   - We don't have explicit COGS values for FY2018\n\n2. Even though we have gross profit margin (24.7%) and net sales ($495,761M) for FY2018, which could help us derive COGS, without the accounts payable figures, we cannot calculate DPO.\n\n3. The formula requires:\n   - Average accounts payable (missing)\n   - COGS (could be derived but not needed without accounts payable)\n   - Change in inventory (available: $43,783M - $43,046M = $737M)\n\n4. Due to missing critical data points, particularly accounts payable figures, we cannot calculate DPO.",
        "answer": "Cannot be calculated due to missing accounts payable data in the provided context."
    },
    "148": {
        "reasoning": "1. From the consolidated statements of income, I need to:\n   - Get operating income and total revenues for both 2018 and 2019\n   - Calculate operating margin (operating income/total revenues) for both years\n   - Find the change between these years\n\n2. For FY2019:\n   - Operating income: $21,987 million\n   - Total revenues: $514,405 million\n   - Operating margin = (21,987/514,405) \u00d7 100 = 4.27%\n\n3. For FY2018:\n   - Operating income: $20,437 million\n   - Total revenues: $500,343 million\n   - Operating margin = (20,437/500,343) \u00d7 100 = 4.08%\n\n4. Calculate year-over-year change:\n   - Change in margin = 4.27% - 4.08% = 0.19%\n   - Rounded to one decimal place = 0.2%",
        "answer": "0.2%"
    },
    "149": {
        "reasoning": "1. Based on the provided context, I can only see the Operating Income from the Consolidated Statements of Income:\n   - FY2020: $20,568M\n   - FY2019: $21,957M\n   - FY2018: $20,437M\n\n2. For a complete EBITDA calculation, we would need depreciation and amortization figures from the cash flow statement, which are not provided in the given context.\n\n3. Without the depreciation and amortization figures, I cannot calculate the true EBITDA margin.\n\n4. While I can see Net Sales figures:\n   - FY2020: $519,926M\n   - FY2019: $510,329M\n   - FY2018: $495,761M\n   These alone are not sufficient for the EBITDA margin calculation.\n\n5. Due to missing critical data (D&A figures), I cannot provide an accurate calculation of the 3-year average unadjusted EBITDA margin.",
        "answer": "Cannot be calculated with the given information as depreciation and amortization figures from the cash flow statement are not provided in the context."
    }
}